Proxy Statement (Form DEF 14A)
)
| ☐ | Preliminary Proxy Statement | |
| ☐ |
Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
|
|
| ☒ | Definitive Proxy Statement | |
| ☐ | Definitive Additional Materials | |
| ☐ | Soliciting Material Pursuant to
§240.14a-12
|
|
| ☒ | No fee required. | |
| ☐ | Fee paid previously with preliminary materials. | |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules
14a-6(i)(1)
and 0-11.
|
|
(Incorporated in
To the shareholders of
You are cordially invited to attend the annual meeting of the shareholders of
|
Date & Time: Thursday |
Place: The Offices of J.J. Viottastraat 52, 1071 JT, |
Record Date: |
||
|
How to Vote |
||||||||
|
Online Vote online at |
By Phone Vote by phone by calling the number located on your |
By Mail If you received a printed version of these proxy |
||||||
|
Your vote is very important.Holders of the Company's shares of common stock, each with a nominal value of €0.06 (the "Common Stock"), held as of |
||||||||
|
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON The Notice of Annual Meeting of Shareholders and the Proxy Statement for the 2025 Annual Meeting of Shareholders, along with the Company's 2024 Annual Report to Shareholders, is available free of charge at www.proxydocs.com/xpro. |
|
2025 Proxy Statement |
At this meeting, you will be asked to consider and vote upon the following proposals:
|
Voting Matters |
For More |
Voting |
||||
| 1. | to elect seven director nominees named in this proxy statement to serve until the Company's annual meeting of shareholders in 2026; |
Page 62 |
FOR |
|||
| 2. | to approve on a non-bindingadvisory basis the compensation of the Company's named executive officers for the year ended |
Page 63 |
FOR |
|||
| 3. | to review the annual report for the fiscal year ended |
Page 64 |
FOR |
|||
| 4. | to discharge the members of the Board from liability in respect of the exercise of their duties during the fiscal year ended |
Page 65 |
FOR |
|||
| 5. | to appoint |
Page 66 |
FOR |
|||
| 6. | to ratify the appointment of |
Page 67 |
FOR |
|||
| 7. | to authorize the Board to repurchase shares up to 10% of the issued share capital, for any legal purpose, through the stock exchange or in a private purchase transaction, at a price between |
Page 68 |
FOR |
|||
| 8. | to authorize the Board to issue shares up to 20% of the issued share capital as of the date of the 2025 annual meeting, for any legal purpose, at the stock exchange or in a private purchase transaction, and during a period of 18 months starting from the date of the 2025 annual meeting. The authorization also includes the authority to restrict or exclude pre-emptiverights upon an issue of shares; and |
Page 69 |
FOR |
|||
| 9. | to transact such other business as may properly come before the annual meeting or any adjournment thereof. | |||||
Pursuant to the "notice and access" rules promulgated by the
I urge you to review carefully the proxy statement, which contains detailed descriptions of the proposals to be voted upon at the annual meeting.
Sincerely,
General Counsel and Secretary
Den Helder,
|
2025 Proxy Statement |
TABLE OF CONTENTS
| QUESTIONS AND ANSWERS | 2 | |||
| MANAGEMENT | 6 | |||
| COMPENSATION COMMITTEE REPORT | 20 | |||
| COMPENSATION DISCUSSION AND ANALYSIS AND EXECUTIVE COMPENSATION | 21 | |||
| 21 | ||||
| 21 | ||||
|
Overview of Executive Compensation and our Compensation Process |
22 | |||
| 24 | ||||
| 24 | ||||
| 31 | ||||
| 31 | ||||
| 32 | ||||
| 33 | ||||
| 35 | ||||
| 35 | ||||
| 36 | ||||
| 36 | ||||
| 37 | ||||
| 38 | ||||
| 39 | ||||
| 39 | ||||
| 39 | ||||
| 46 | ||||
| 46 | ||||
| 47 | ||||
| 49 | ||||
| 53 | ||||
| AUDIT COMMITTEE REPORT | 54 | |||
| INFORMATION ABOUT OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | 56 | |||
| TRANSACTIONS WITH RELATED PERSONS | 58 | |||
| SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT | 60 | |||
|
FREQUENTLY REFERENCED PAGES |
||||||||
| Directors and Executive Officers | 6 | |||||||
| Committees of the Board | 14 | |||||||
| Say-on-Pay | 22 | |||||||
| Stock Ownership Guidelines | 31 | |||||||
| Director Compensation | 46 | |||||||
(A Dutch limited liability company, incorporated in
PROXY STATEMENT
ANNUAL MEETING OF SHAREHOLDERS
This proxy statement is being furnished to you in connection with the solicitation of proxies by the Board of the Company for use at the Company's annual meeting.
In this proxy statement, unless indicated otherwise, "we," "our," "us," "Expro," and the "Company" refer to
As further described below, the
Mr.
Our Common Stock is traded on the NYSE. Therefore, in accordance with rules and regulations adopted by the
|
2025 Proxy Statement | 1 |
QUESTIONS AND ANSWERS
Shareholders are urged to read this proxy statement carefully in its entirety. FOR COPIES OF THIS PROXY STATEMENT, OR IF YOU HAVE ANY QUESTIONS ABOUT THE ANNUAL MEETING OR NEED ASSISTANCE VOTING, PLEASE CONTACT OUR INVESTOR RELATIONS DEPARTMENT AT [email protected].
| Q: |
When and where is the annual meeting? |
| A: |
The annual meeting will be held on |
| Q: |
Who is soliciting my proxy? |
| A: |
The Board is sending you this proxy statement in connection with their solicitation of proxies for use at the Company's 2025 annual meeting. |
| Q: |
Who is entitled to vote at the annual meeting? |
| A: |
All shareholders who own shares of Common Stock as of the record date, |
Each shareholder is entitled to one vote for each share of Common Stock owned by them on the record date,
The Company is sending the Notice to shareholders of record as of
| Q: |
What vote is required to approve the proposals? |
| A: |
The affirmative vote of a simple majority of the votes cast is required to elect each director nominee and to approve each item on the agenda at the annual meeting. Under Dutch law, there is no required quorum for shareholder action at a properly convened shareholder meeting. Further, a director nominee proposal made by the Board and submitted on time is binding. However, the general meeting may render the proposal non-bindingby a resolution to that effect adopted with a majority of no less than two-thirdsof the votes cast, representing over one-halfof the issued capital. |
A properly executed proxy (for a holder as of the record date of the annual meeting) will be voted in accordance with the instructions on the proxy. If you properly complete and submit a proxy, but do not indicate any contrary voting instructions, your shares will be voted as follows:
| • |
"FOR" the election of each of the director nominees named in this proxy statement ("Item One"); |
| • |
"FOR" the approval on a non-bindingadvisory basis of the compensation of the Company's named executive officers ("Item Two"); |
| • |
"FOR" the confirmation and ratification of the preparation of the Company's statutory annual accounts and annual report in the English language and the confirmation and adoption of the annual accounts for the fiscal year ended |
| • |
"FOR" the discharge of the members of the Board from liability in respect of the exercise of their duties during the fiscal year ended |
| • |
"FOR" the appointment of |
|
2 | 2025 Proxy Statement |
QUESTIONS AND ANSWERS
| • |
"FOR" the ratification of the appointment of |
| • |
"FOR" the authorization of the Board to repurchase shares up to 10% of the issued share capital, for any legal purpose, through the stock exchange or in a private purchase transaction, at a price between |
| • |
"FOR" the authorization of the Board to issue shares up to 20% of the issued share capital as of the date of the 2025 annual meeting, for any legal purpose, at the stock exchange or in a private purchase transaction, and during a period of 18 months starting from the date of the 2025 annual meeting. The authorization also includes the authority to restrict or exclude pre-emptiverights upon an issue of shares ("Item Eight"). |
| Q: |
Why did I receive a Notice in the mail regarding the Internet availability of proxy materials instead of a full set of proxy materials? |
| A: |
In accordance with |
| Q: |
Can I vote my stock by filling out and returning the Notice? |
| A: |
No. The Notice will, however, provide instructions on how to vote by internet, by telephone, by requesting and returning a paper proxy card, or by personally attending and voting at the annual meeting. |
| Q: |
How can I access the proxy materials over the Internet? |
| A: |
Your Notice, proxy card and/or voting instruction card will contain instructions on how to view our proxy materials for the annual meeting on the Internet. Our proxy materials are also available at www.proxydocs.com/xpro. |
| Q: |
How do I vote? |
| A: |
If you are a shareholder of record as of May8, 2025, you may vote by any of the following four methods: |
| • |
Internet. Vote on the Internet at www.proxyvote.com. This website also allows electronic proxy voting using smartphones, tablets and other web-connectedmobile devices (additional charges may apply pursuant to your service provider plan). Simply follow the instructions on the Notice, or if you received a proxy card by mail, follow the instructions on the proxy card and you can confirm that your vote has been properly recorded. If you vote on the Internet, you can request electronic delivery of future proxy materials. Internet voting facilities will be available 24 hours a day and will close at |
| • |
Telephone. Vote by telephone by following the instructions on the Notice. Easy-to-followvoice prompts allow you to vote your shares of Common Stock and confirm that your vote has been properly recorded. Telephone voting facilities for shareholders will be available 24 hours a day and will close at |
| • |
Mail. If you have requested and received a proxy card by mail, vote by mail by completing, signing, dating and returning your proxy card in the pre-addressed,postage-paid envelope provided. If you vote by mail and your proxy card is returned unsigned, then your vote cannot be counted. If you vote by mail and the returned proxy card is signed without indicating how you want to vote, then your proxy will be voted as recommended by the Board. If you mail in your proxy card, it must be received by the Company before the voting polls close at the annual meeting. |
| • |
In person. You may attend and vote at the annual meeting. |
The Board recommends that you vote using one of the first three methods discussed above, as it is not practical for most shareholders to attend and vote at the annual meeting. Using one of the first three methods discussed above to vote will not limit your right to vote at the annual meeting if you later decide to attend in person.
|
2025 Proxy Statement | 3 |
QUESTIONS AND ANSWERS
If you are a beneficial owner of Common Stock held in street name, you must either direct your broker or other nominee as to how to vote your Common Stock, or obtain a "legal" proxy from your broker or other nominee to vote at the annual meeting. Please refer to the voter instruction card provided by your broker or other nominee for specific instructions on methods of voting.
Even if you plan to attend the annual meeting, please vote your proxy in advance of the annual meeting using one of the methods above as soon as possible so that your shares of Common Stock will be represented at the annual meeting if for any reason you are unable to attend in person.
| Q: |
What do I do if I want to change my vote after I have already voted by proxy? |
| A: |
If you are a shareholder of record as of the record date, you may change or revoke your vote at any time before the voting polls close at the annual meeting by: |
| • |
voting at a later time by Internet or telephone until |
| • |
delivering a later-dated, executed proxy card to the address indicated in the envelope accompanying the proxy card; |
| • |
delivering a written notice of revocation of your proxy to the Company, Attention: Corporate Secretary at |
| • |
attending the annual meeting and voting in person. Please note that attendance at the annual meeting will not by itself (i.e., without also voting) revoke a previously granted proxy. |
If you are a beneficial owner of Common Stock held in street name and you have instructed your broker or other nominee to vote your Common Stock, you must follow the procedure your broker or other nominee provides to change those instructions. You may also vote in person at the annual meeting if you obtain a "legal" proxy from your broker or other nominee.
| Q: |
If my shares of Common Stock are held in "street name" by my broker or other nominee, will my broker or other nominee vote my Common Stock for me? How do "abstentions" count? |
| A: |
Brokers who hold shares in street name for customers are required to vote shares in accordance with instructions received from the beneficial owners. Brokers are permitted to vote on discretionary items if they have not received instructions from the beneficial owners, but they are not permitted to vote (a "broker non-vote")on non-discretionaryitems absent instructions from the beneficial owner. We urge you to provide voting instructions promptly to your broker to ensure that your shares are voted on all of the proposals, even if you plan to attend the annual meeting. Neither abstentions nor broker non-votes,if any, will have any effect on the outcome of voting on items on the agenda for the annual meeting because they are not considered "votes cast." If any other business properly comes before the annual meeting, your shares will be voted in accordance with the discretion of the holders of the proxy. The Board knows of no matters, other than those previously stated, to be presented for consideration at the annual meeting. |
| Q: |
Who covers the expense of the proxy solicitation? |
| A: |
The expense of preparing, printing and mailing the Notice and any proxy statement and the proxies solicited hereby will be borne by the Company. In addition to the use of the mail, proxies may be solicited by employees of the Company, without additional remuneration, by mail, phone, fax or in person. The Company will also request brokerage firms, banks, nominees, custodians and fiduciaries to forward proxy materials to the beneficial owners of the Company's Common Stock as of |
|
4 | 2025 Proxy Statement |
QUESTIONS AND ANSWERS
| Q: |
Are dissenters' rights available to holders of Common Stock? |
| A: |
Subject to certain exceptions, Dutch law does not recognize the concept of dissenters' rights. Accordingly, dissenters' rights are not available to the holders of the Company's Common Stock with respect to matters to be voted upon at the annual meeting. |
| Q: |
Who can I contact for further information? |
| A: |
If you have questions or need assistance voting, please contact Investor Relations at [email protected]. |
|
2025 Proxy Statement | 5 |
MANAGEMENT
Board Structure
The Company currently has a one-tierboard structure. Under the Company's Articles, the Board must consist of one or more executive directors and one or more non-executivedirectors. Only a non-executivedirector can serve as Chair of the Board. This structure is customary for Dutch companies. Executive directors are primarily charged with the Company's day-to-dayoperations and non-executivedirectors are primarily charged with the supervision of the performance of the duties of the directors.
The Board exercises oversight of management with the Company's interests in mind. At the annual meeting, the terms of our eight incumbent directors will expire.
Directors and Executive Officers
Set forth below are the names and ages of the director nominees standing for election, as well as the names, ages and positions of the Company's executive officers. All directors are elected for a term of one year or to serve until their successors are elected and qualified or upon earlier of death, disability, resignation or removal. All executive officers hold office until their successors are elected and qualified or upon earlier of death, disability, resignation or removal.
All of the director nominees are current directors and were last elected by shareholders at the 2024 annual meeting of shareholders. As described in greater detail on page 58,
|
|
Age | Position | ||
|
|
64 | Chairman of the Board and non-executivedirector | ||
|
|
55 | President and Chief Executive Officer and executive director | ||
|
|
44 | Non-executivedirector | ||
|
|
63 | Non-executivedirector | ||
|
|
66 | Non-executivedirector | ||
|
|
60 | Non-executivedirector | ||
|
|
71 | Non-executivedirector | ||
|
|
61 | Chief Financial Officer | ||
|
|
62 | Chief Operating Officer | ||
|
|
58 | General Counsel and Secretary | ||
|
|
57 | Chief Technology Officer | ||
|
6 | 2025 Proxy Statement |
MANAGEMENT
|
Robert |
Chairman of the Board |
|
|
Director since: 2017 Committee Membership: • Compensation |
|
|
|
Skills and Qualifications |
||
|
|
President and Chief Executive Officer |
|
|
Director since: 2021 Committee Membership: • None |
|
|
|
Skills and Qualifications |
||
|
2025 Proxy Statement | 7 |
MANAGEMENT
|
Eitan Arbeter |
Non-Executive Director |
|
|
Director since: 2021 Committee Membership: • Compensation |
|
|
|
Skills and Qualifications |
||
|
Lisa L. Troe |
Non-Executive Director |
|
|
Director since: 2021 Committee Membership: • Audit • Nominating and Governance |
|
|
|
Skills and Qualifications |
||
|
8 | 2025 Proxy Statement |
MANAGEMENT
|
Brian Truelove |
Non-Executive Director |
|
|
Director since: 2021 Committee Membership: • Audit • Nominating and Governance |
|
|
|
Skills and Qualifications During his time with |
||
|
Frances |
Non-Executive Director |
|
|
Director since: 2023 Committee Membership: • Audit |
|
|
|
Skills and Qualifications |
||
|
2025 Proxy Statement | 9 |
MANAGEMENT
|
Eileen G. Whelley |
Non-Executive Director |
|
|
Director since: 2021 Committee Membership: • Compensation • Nominating and Governance |
|
|
|
Skills and Qualifications |
||
|
10 | 2025 Proxy Statement |
MANAGEMENT
|
Quinn Fanning |
Chief Financial Officer |
|
|
|
||
|
Skills and Qualifications Prior to joining Tidewater, |
||
|
Alistair Geddes |
Chief Operating Officer |
|
|
|
||
|
Skills and Qualifications |
||
|
2025 Proxy Statement | 11 |
MANAGEMENT
|
John McAlister |
General Counsel and Secretary |
|
|
|
||
|
Skills and Qualifications Prior to joining Legacy Expro, |
||
|
Steven Russell |
Chief Technology Officer |
|
|
|
||
|
Skills and Qualifications Previously, |
||
|
12 | 2025 Proxy Statement |
MANAGEMENT
Director Nominee Highlights
As presented in the chart below, we believe our Board nominees offer a diverse range of key skills and experiences to provide effective oversight of the Company and create long-term sustainable growth for our Company through successful execution of the Company's strategic plan. Below is a high-level summary which highlights certain of the Board nominees' skills, qualifications and experiences and is not intended to be an exhaustive list of each director nominee's contributions to the Board.
| Drummond | Jardon | Arbeter | Troe | Truelove | Vallejo | Whelley | |||||||||||||||||||||||||||||
|
Demographics |
|||||||||||||||||||||||||||||||||||
|
Age |
64 | 55 | 44 | 63 | 66 | 60 | 71 | ||||||||||||||||||||||||||||
|
Gender |
M | M | M | F | M | F | F | ||||||||||||||||||||||||||||
|
Ethnic Diversity (Y/N) |
N | N | N | N | N | Y | N | ||||||||||||||||||||||||||||
|
Tenure on This Board (yrs) |
7 | 2 | 2 | 2 | 2 | 1 | 2 | ||||||||||||||||||||||||||||
|
Total # other Public Board Commitments |
1 | 0 | 1 | 0 | 1 | 2 | 0 | ||||||||||||||||||||||||||||
|
Compliance |
|||||||||||||||||||||||||||||||||||
|
Independent Director |
X | X | X | X | X | X | |||||||||||||||||||||||||||||
|
Audit Committee Financial Expert (SEC) |
X | X | X | ||||||||||||||||||||||||||||||||
|
Experience |
|||||||||||||||||||||||||||||||||||
|
|
X | X | |||||||||||||||||||||||||||||||||
|
Public Company CFO |
|||||||||||||||||||||||||||||||||||
|
|
X | X | X | X | X | X | |||||||||||||||||||||||||||||
|
Public Company Board Director |
X | X | X | X | X | X | X | ||||||||||||||||||||||||||||
|
Audit Committee |
X | X | X | X | |||||||||||||||||||||||||||||||
|
Compensation Committee |
X | X | X | X | |||||||||||||||||||||||||||||||
|
Nom/Gov Committee |
X | X | X | X | X | ||||||||||||||||||||||||||||||
|
Oil and Gas Industry |
X | X | X | X | X | ||||||||||||||||||||||||||||||
|
International |
X | X | X | ||||||||||||||||||||||||||||||||
|
Expertise* |
|||||||||||||||||||||||||||||||||||
|
Finance/Accounting |
X | X | X | X | X | ||||||||||||||||||||||||||||||
|
Banking |
X | ||||||||||||||||||||||||||||||||||
|
Operations |
X | X | X | ||||||||||||||||||||||||||||||||
|
Technology (other than IT), R&D |
X | X | |||||||||||||||||||||||||||||||||
|
IT/Cybersecurity |
X | ||||||||||||||||||||||||||||||||||
|
HSE/Risk Management/Audit |
X | X | X | X | X | ||||||||||||||||||||||||||||||
|
Strategic Planning |
X | X | X | X | X | X | X | ||||||||||||||||||||||||||||
|
M&A, Deal Making |
X | X | X | X | X | X | |||||||||||||||||||||||||||||
|
HR/Compensation |
X | X | X | ||||||||||||||||||||||||||||||||
|
Legal/Regulatory Affairs |
X | ||||||||||||||||||||||||||||||||||
|
Sales/Marketing/Commercial |
X | X | |||||||||||||||||||||||||||||||||
|
Investor Relations |
X | X | |||||||||||||||||||||||||||||||||
|
Supply Chain/Logistics |
X | ||||||||||||||||||||||||||||||||||
|
Environmental/Social |
X | ||||||||||||||||||||||||||||||||||
| * |
Qualification for Expertise is that the nominee served in a role where they extensively used this expertise. Simply managing the function does not qualify unless a direct role was included. |
|
2025 Proxy Statement | 13 |
MANAGEMENT
Director Independence
The Board assesses director independence on a case-by-casebasis, in each case consistent with applicable legal requirements and the listing standards of the NYSE. After reviewing all relationships each director has with the Company, including the nature and extent of any business relationships between the Company and each director, as well as any significant charitable contributions the Company makes to organizations where its directors serve as board members or executive officers and transactions discussed under "Transactions with Related Persons" below, the Board has affirmatively determined each of
Committees of the Board
The Board currently has three standing committees: the Audit Committee, the Compensation Committee and the
| Audit Committee | ||||
|
Members: * Audit Committee Financial Expert |
Primary responsibilities: The Audit Committee oversees, reviews, acts on and reports to the Board on various auditing and accounting matters, including: • the selection of the Company's independent accountants; • the scope of the Company's annual audits; • fees to be paid to the independent accountants; • the performance of the Company's independent accountants and the Company's accounting practices. |
|||
In addition, the Audit Committee oversees the Company's compliance programs relating to legal and regulatory requirements. On a quarterly basis, the Audit Committee meetings are typically attended by the Company's Chief Financial Officer, General Counsel, representatives from its external and internal auditors, and others as necessary and appropriate. The Company has adopted an audit committee charter defining the committee's primary duties in a manner consistent with the rules of the
Each member satisfies the heightened requirements for independence under Rule 10A-3of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). An "audit committee financial expert" is defined as a person who, based on his or her experience, possesses the attributes outlined in Regulation S-KItem 407(d)(5)(ii) and (iii). The Board has determined that
The Audit Committee is delegated all authority of the Board as may be required or advisable to fulfill its purpose. The Audit Committee may form and delegate some or all of its authority to subcommittees or to its Chair when it deems appropriate. Meetings may, at the discretion of the Audit Committee, include other directors, members of the Company's management, consultants or advisors, and such other persons as the Audit Committee believes to be necessary or appropriate.
If re-electedto the Board,
|
14 | 2025 Proxy Statement |
MANAGEMENT
| Compensation Committee | ||||
|
Members: |
Primary responsibilities: The Compensation Committee oversees, reviews, acts on and reports to the Board on various compensation matters, including: • the compensation of the Company's executive officers and directors; • the Compensation Discussion and Analysis included in the Company's proxy statement or Annual Report on Form 10-Kand the Compensation Committee Report; • compensation matters required by • and the discharge of the Board's responsibilities relating to compensation of the Company's executive officers and directors. |
|||
Each member satisfies the heightened requirements for compensation committee independence set out in Section 303A.02(a)(ii) of the NYSE Manual and Rule 10C-1of the Exchange Act. The Company has adopted a compensation committee charter defining the committee's primary duties, which is available at www.expro.com.
The Compensation Committee is delegated all authority of the Board as may be required or advisable to fulfill its purpose. The Compensation Committee may form and delegate some or all of its authority to subcommittees or to its Chair when it deems appropriate. Meetings may, at the discretion of the Compensation Committee, include other directors, members of the Company's management, consultants or advisors, and such other persons as the Compensation Committee believes to be necessary or appropriate. Further,
If re-electedto the Board,
| Nominating and Governance Committee | ||||
|
Members: |
Primary responsibilities: • the selection of director nominees; • composition of the Board and its committees; • compliance with corporate governance guidelines; • enterprise risk management, including risks related to matters including compliance, and information technology and cybersecurity as well as artificial intelligence; • annual performance evaluations of the Board and its committees; • and succession planning for the Chief Executive Officer. |
|||
It also oversees management's effort to increase the Company's environmental, social and governance related policies and initiatives, including climate- and human capital-related risks. The Company has adopted a
If re-electedto the Board,
|
2025 Proxy Statement | 15 |
MANAGEMENT
Board and Committee Meetings
During 2024, the Board held six meetings, the Audit Committee of the Board held four meetings, the Compensation Committee of the Board held six meetings, and the
Selection of Director Nominees and Shareholder Participation
The number of members of the Board is determined from time to time at a general meeting upon a proposal by the Board. Pursuant to the Company's Articles, directors are appointed by the shareholders voting at the general meeting upon a proposal of the Board. A proposal made by the Board and submitted on time is binding. However, the general meeting may render the proposal non-bindingby a resolution to that effect adopted with a majority of no less than two-thirdsof the votes cast, representing over one-halfof the issued capital. Under Dutch law, if a binding proposal for the relevant board seat is made, then that person is deemed elected if no resolution is adopted by the general meeting to render the proposal non-binding.When making a proposal, subject to applicable law, the Board must observe the terms of the Director Nomination Agreement (as defined above).
Pursuant to the Director Nomination Agreement,
In evaluating director candidates, the Company assesses whether a candidate possesses the integrity, judgment, knowledge, experience, skills and expertise that are likely to enhance the Board's ability to oversee and direct the Company's affairs and business, including, when applicable, to enhance the ability of committees of the Board to fulfill their duties and the quality of the Board's deliberations and decisions. In evaluating directors under its diversity policy, the Company considers diversity in its broadest sense, including persons diverse in perspectives, personal and professional experiences, geography, gender, race and ethnicity. The Board assesses the effectiveness of this policy in connection with its annual evaluation of the Board and its committees.
In order to assist the Board in the director selection process as well as in the selection of Board committee composition, the
The Company will consider director candidates recommended by shareholders on the same basis as candidates recommended by the Board and other sources. For a description of the procedures and qualifications required to submit shareholder proposals, including for nominating directors, please see "Shareholder Proposals." Other than as described above, the Company does not have a policy regarding consideration of director candidates submitted by shareholders.
Dutch Governance Code and Dutch Law Diversity Requirements and Our Board
Since
|
16 | 2025 Proxy Statement |
MANAGEMENT
| - |
Under this law, the following rules apply: |
| i. |
A company must set suitable and ambitious targets - in the form of a percentage or number - to ensure a balanced board and group of senior officers/employees (as determined by the company) in terms of gender. |
| ii. |
A company must prepare a plan to meet those gender targets. |
| iii. |
Each year, by |
| iv. |
As part of its report to the Dutch Social Economic Counsel, a company must also indicate what its targets were, what its plans were to meet those targets and, if applicable, why it failed to meet those targets. |
The importance of diversity is recognized by the Company. The Company's diversity policy is part of the Corporate Governance Guidelines and the Nominating and Governance Committee Charter, which are under regular consideration and review by the Board. The Company's diversity policy is maintained in compliance with the requirements of the Dutch Corporate Governance Code, which is applicable to the Company. The Company strives to give appropriate weight to the diversity policy in the selection and appointment process, while taking into account the overall profile and selection criteria for the appointment of suitable candidates.
The Corporate Governance Guidelines confirm that an important component of the Board is diversity. In addition, the Board believes that the Company should strive to take into account a balanced gender representation as much as possible when making nominations for election. If the proposed slate of director nominees is elected at the 2025 annual meeting, then three of the seven directors (or 42.9%) will be women.
The Company believes that the current composition of the Board, taking into account the knowledge and experience of the current members, is in the best interest of the Company and its businesses. In the future, we will continue to pursue a diverse composition for the Board, although it is not possible to predict when we will be able to fully achieve all targets.
Communications with Directors of the Company
The Board welcomes questions or comments about the Company and its operations. Interested parties who wish to communicate with the Board, the Chair, the non-employeeor independent directors, or any individual director may write to
| • |
forward the communication to the director or directors to whom it is addressed; |
| • |
refer the inquiry to the appropriate corporate department if it is a matter that does not appear to require direct attention by the Board or an individual director; or |
| • |
not forward the communication if it is primarily commercial in nature or if it relates to an improper or irrelevant topic. |
Compensation Committee Interlocks and Insider Participation
None of the Company's executive officers serve on the board of directors or compensation committee of a company that has an executive officer that serves on the Board. No member of the Board is an executive officer of a company in which one of the Company's executive officers serves as a member of the board of directors or compensation committee of that company.
Risk Oversight
The Board is actively involved in oversight of risks that could affect the Company. This oversight function is conducted primarily through the Audit Committee and the
|
2025 Proxy Statement | 17 |
MANAGEMENT
Company's system of internal controls and risks relating to financial reporting, legal, regulatory and accounting compliance.
Executive Sessions of the Board
The non-managementdirectors have regularly scheduled meetings in executive session. The Chairman of the Board will preside at these meetings. In the event the non-managementdirectors include directors who are not independent under the listing requirements of the NYSE, then at least once a year, there will be an executive session including only independent directors. The Chairman of the Board is responsible for preparing an agenda for the meetings of the independent directors in executive session. If re-electedto the Board,
Board Leadership Structure
Under Dutch law, only a non-executivedirector can be the Chairman of the Board. Currently,
Annual Performance Evaluation of the Board and Its Committees
The Board conducts an annual self-evaluation to determine whether it is functioning effectively. The self-evaluation process is overseen by the Board, in consultation with the
The Board's committees also conduct an annual self-evaluation to determine whether the committees are functioning effectively. The self-evaluation process is overseen by the Board. As part of this process, the Chair of each committee will receive comments from each of the committee members in response to a distributed questionnaire and will determine whether the applicable committee or the Board should discuss the findings.
Code of Ethics for Chief Executive Officer, Chief Financial Officer, Controller and Certain Other Officers
The Board has adopted a Financial Code of Ethics for its Chief Executive Officer, Chief Financial Officer and all other financial and accounting officers. Any change to, or waiver from, the Financial Code of Ethics will be promptly disclosed as required by applicable
Code of Conduct
The Board has adopted a Code of Conduct applicable to the Company's employees, directors and officers, in accordance with applicable
|
18 | 2025 Proxy Statement |
, and the Company intends to disclose any amendments or waivers to its Code of Conduct via its website.
.
an insider trading policy (the "Insider Trading Policy"), which governs the purchase, sale and other dispositions of our securities by directors, officers and employees (as well as certain persons related to them). We believe this policy and the procedures that the Company follows are reasonably designed to promote compliance with insider trading and market abuse laws, rules and regulations and the NYSE listing standards. Among other things, the Insider Trading Policy (i) prohibits trading by covered persons in our securities while aware of material,
information about the Company or in the securities of another company while aware of material,
information about such company gained in the course of working for the Company, and misusing such information, such as by "tipping" or making unauthorized disclosure of material,
information and (ii) provides for trading windows and
processes that apply to certain covered individuals. The Company's Insider Trading Policy also prohibits hedging transactions involving Company securities and other transactions involving Company-based derivative securities. "Derivative securities" are defined in the Insider Trading Policy as options, warrants, stock appreciation rights, convertible notes or similar rights whose value is derived from the value of an equity security, such as Company common stock. Transactions in derivative securities include, but are not limited to, trading in Company-based option contracts, transactions in straddles or collars, transactions in debt that may be convertible into Company common stock, and writing puts or calls. The Insider Trading Policy does not, however, restrict holding awards such as options, restricted stock, restricted stock units or other derivative securities granted under a Company equity incentive plan. However, exercising and settling any such awards must be done in compliance with the terms of the Insider Trading Policy. The Company's Insider Trading Policy also prohibits pledging Company securities as collateral, including holding shares in a margin account. The Insider Trading Policy was filed as Exhibit 19.1 to our Annual Report on Form
for the fiscal year ended 2024 filed on
|
2025 Proxy Statement
|
19
|
COMPENSATION COMMITTEE REPORT
The Board reviewed and discussed the Compensation Discussion and Analysis required by Item 402(b) of Regulation S-Kpromulgated by the
Submitted by the Compensation Committee
|
20 | 2025 Proxy Statement |
COMPENSATION DISCUSSION AND ANALYSIS AND EXECUTIVE COMPENSATION
TABLE OF CONTENTS
| COMPENSATION DISCUSSION AND ANALYSIS | 21 | |||
| 21 | ||||
|
Overview of Executive Compensation and our Compensation Process |
22 | |||
| 24 | ||||
| 24 | ||||
| 31 | ||||
| 31 | ||||
| 32 | ||||
| 33 | ||||
| EXECUTIVE COMPENSATION | 35 | |||
| 35 | ||||
| 36 | ||||
| 36 | ||||
|
Narrative Description to the Summary Compensation Table and the Grants of |
37 | |||
| 38 | ||||
| 39 | ||||
| 39 | ||||
| 39 | ||||
| 46 | ||||
| 46 | ||||
| 47 | ||||
| 49 | ||||
| 53 | ||||
COMPENSATION DISCUSSION
AND ANALYSIS
Executive Summary
This Compensation Discussion and Analysis (this "CD&A") is intended to provide perspective regarding the Company's executive compensation program for 2024, and the philosophy, objectives, compensation processes, and key components of compensation established by the
|
|
|
2025 Proxy Statement | 21 |
COMPENSATION DISCUSSION AND ANALYSIS
The Company continues to maintain executive compensation programs that reflect positive corporate governance features. Below is a summary of those practices:
| WHAT WE DO | WHAT WE DON'T DO | |||||||
|
☑ |
Utilize variable, at-riskperformance-based elements to align pay and performance for a large portion of compensation. |
☒ |
Permit hedging or pledging |
|||||
|
☑ |
Maintain stock ownership requirements for officers and non-employeedirectors. |
☒ |
Provide single trigger post-employment and change-in-controlprovisions. |
|||||
|
☑ |
Utilize multiple performance metrics across our short- and long-term incentive plans. |
☒ |
Maintain individual employment agreements providing cash severance following a termination of employment (other than with respect to an individual agreement with our CEO). |
|||||
|
☑ |
Limit maximum payout under our short- and long-term incentive plans. |
☒ |
Backdate or reprice stock option awards. |
|||||
|
☑ |
Engage an independent outside consultant to help the Compensation Committee evaluate and monitor our compensation program. |
☒ |
Provide tax gross-upson change-in-controlbenefits. |
|||||
|
☑ |
Include clawback provisions in key agreements, and maintain policies that allow us to recover all incentive compensation paid to covered employees, including our Named Executive Officers, in the event of an accounting restatement or certain acts of misconduct. |
☒ |
Provide excessive perquisites. |
|||||
|
☑ |
Utilize reasonable post-employment and change-in-controlprovisions that do not allow single-trigger change-in-controlpayments and do not pay severance in the event of voluntary termination. |
|||||||
|
☑ |
Annually review all officer compensation opportunities against peer groups. |
|||||||
| 96%
approval of 2024 say-on-pay vote |
Say-on-Pay
We held our last advisory say-on-payand say-on-frequencyvotes regarding executive compensation at the Company's 2024 Annual Meeting. At that meeting, 96% of the votes cast by our shareholders approved the compensation paid to our Named Executive Officers as described in the CD&A and the other related compensation tables and disclosures contained in our Proxy Statement filed with the
Overview of Executive Compensation and our Compensation Process
Key Objectives of the Company's Compensation Program
| • |
attract, motivate, retain and reward employees by offering competitive and flexible compensation and benefits packages |
| • |
promote alignment with our business strategy and shareholder interests by tying a substantial portion of executive pay to performance |
| • |
ensure compliance with applicable law, alignment between metrics and risk, and promotion of global equity and consistency |
| • |
reward long-term profitability |
| • |
discourage excessive risk-taking |
|
22 | 2025 Proxy Statement |
COMPENSATION DISCUSSION AND ANALYSIS
These objectives are taken into consideration when creating the Company's compensation arrangements, when setting each element of compensation under those programs, and when determining the proper mix of the various compensation elements for each of the Named Executive Officers. We intend to annually re-evaluate whetherour compensation programs and the levels of pay awarded under each element of compensation achieve these objectives.
The Compensation Committee has primary responsibility over our executive compensation program, including the decisions regarding the various levels and forms of compensation for each of the Company's Named Executive Officers. The Compensation Committee's primary objectives are to set competitive pay practices and to utilize equity compensation to align the incentives of executives of the Company with the interests of shareholders by tying a significant portion of compensation directly to performance.
As a result of the decisions of the Company's Compensation Committee, the compensation of the Company's Named Executive Officers consisted primarily of the following items, which are described in greater detail in the sections below:
| • |
base salary; |
| • |
annual cash incentive awards; |
| • |
equity-based long-term incentive compensation (comprised of both performance-based equity awards and time-based vesting equity awards); and |
| • |
severance benefits for certain terminations of employment. |
Independent Compensation Consultant
To ensure the Company continues to meet its compensation objectives as a public company, we work with
The Compensation Committee has considered and assessed relevant factors that could give rise to a potential conflict of interest with respect to the independent compensation consultant that provided services in 2024. Based on this review, the Compensation Committee determined that there are no conflicts of interest raised by the work performed by Meridian.
The Compensation Committee reviews a competitive market analysis of officer compensation each year provided by Meridian. This data helps inform pay decisions for the upcoming year. The peer group used in the market analysis (which was used to inform 2024 compensation) was:
|
|
|
|
||
| Patterson-UTI |
||||
The Compensation Committee utilizes the peer group for purposes of obtaining data regarding the compensation practices of our peers in order to evaluate the relative appropriateness of our compensation practices. Meridian worked with our Compensation Committee to select this group of publicly traded international companies from the same or similar industries and within a relevant range of our annual sales and market capitalization. The Compensation Committee evaluates this peer group annually in advance of the annual compensation market benchmarking analyses provided by Meridian. The Compensation Committee takes peer group market data into consideration when establishing officer pay levels, but also considers other relevant factors such as performance,
|
2025 Proxy Statement | 23 |
COMPENSATION DISCUSSION AND ANALYSIS
experience, internal alignment, scope of the role, and other relevant factors when making pay decisions. The Compensation Committee also uses market data from the same peer group in evaluating non-employee
Named Executive Officers
This CD&A provides information regarding the executive compensation program for the following executive officers (collectively, the "Named Executive Officers").
|
President and |
Chief Financial Officer |
Chief Operating Officer |
General Counsel |
Chief Technology Officer |
Components of the Company's Executive Compensation Program
For 2024, in addition to a base salary, each of the Named Executive Officers was eligible to receive a short-term cash incentive bonus and a long-term incentive equity award. The Company believes its mix of compensation aligns its executives' compensation with the Company's short-term and long-term goals consistent with the interests of the Company's shareholders.
The chart below summarizes the percentage of the Chief Executive Officer's and the average of the other Named Executive Officers' target compensation from base salary, cash incentives and equity awards.
|
⬛Base Salary ⬛Target Cash Incentives ⬛Target Equity Awards |
||
| (1) |
The percentage of each compensation element reflected above is based on the target amounts set by the Compensation Committee. For base salary, reflects the base salary as increased mid-yearby the Compensation Committee, as described below. |
Below is a description of each of the principal elements of the Company's compensation programs in effect as of the close of our most recent fiscal year and the Company's view on these elements. The Company recognizes that in connection with the review the Board or Compensation Committee undertakes with Meridian, the goals themselves and the methods of implementing those goals may change in the future.
|
24 | 2025 Proxy Statement |
COMPENSATION DISCUSSION AND ANALYSIS
Base Salary
Base salary is a fixed component of officer compensation and is reviewed and approved annually by the Compensation Committee. In setting the base salaries for 2024, the Company's Compensation Committee considered various factors, including current market conditions, market and peer group data provided by Meridian, the individual's performance, experience, scope of responsibilities, and the overall compensation package received by each Named Executive Officer. After reviewing market and peer group data, Compensation Committee implemented merit increases to the base salaries of Messrs. Fanning, McAlister and Russell, effective mid-yearduring 2024. The Compensation Committee did not make any changes to the base salaries of Messrs. Jardon and Geddes.
The 2024 annual base salary for each of the Named Executive Officers is set forth below.
|
|
Annual Base Salary after mid-year increase |
Annual Base Salary prior to mid-year increase |
% Change | ||||||||||||
|
|
$ |
1,000,000 |
$ |
1,000,000 |
- |
||||||||||
|
|
$ |
465,000 |
$ |
450,000 |
3% |
||||||||||
|
|
$ |
529,200 |
$ |
529,200 |
- |
||||||||||
|
|
$ |
422,193 |
* |
$ |
387,885 |
* |
9% |
||||||||
|
|
$ |
440,000 |
$ |
425,000 |
4% |
||||||||||
| * |
Converted to USD from GBP using an exchange ratio of |
Annual Cash Incentives
Our annual short-term incentive program (STI) in 2024 was designed to provide management, including our Named Executive Officers, with an annual incentive opportunity tied to certain metrics measuring the Company's performance. The annual incentive program measures performance over the full fiscal year. For 2024, each officer had an assigned target annual incentive expressed as a percentage of base salary, as shown in the table below.
|
|
Target Annual Incentive Award (% of Annual Base Salary) |
Target Incentive Award Amount ($) |
||||||||
|
|
125 |
% |
$ |
1,250,000 |
||||||
|
|
100 |
% |
$ |
465,000 |
||||||
|
|
100 |
% |
$ |
529,200 |
||||||
|
|
100 |
% |
$ |
422,193 |
* |
|||||
|
|
100 |
% |
$ |
440,000 |
||||||
| * |
Converted to USD from GBP using an exchange ratio of |
The amounts listed in the table above reflect each individual's STI target award for 2024, based on a level of achievement that results in a 100% payout of their target annual incentive award.
For the Named Executive Officers, the target incentive opportunity granted for 2024 was dependent on the Company's achievement of four corporate-wide numerical performance goals. For 2024, the four metrics selected and their respective weighting were set at planned budgeted amounts in
In
|
2025 Proxy Statement | 25 |
COMPENSATION DISCUSSION AND ANALYSIS
|
Metric |
Weighting | Threshold (50% Payout) |
Target (100% Payout) |
Maximum (200% Payout) |
||||||||||||||||
|
Adjusted EBITDA(1) |
50.0% |
|
|
|
||||||||||||||||
|
Free Cash Flow(2) |
35.0% |
|
|
|
||||||||||||||||
|
TRCF(3) |
10.0% |
1.12 |
1.06 |
n/a |
||||||||||||||||
|
ESG(4) |
5.0% |
1000 tonnes |
1140 tonnes |
n/a |
||||||||||||||||
| (1) |
"Adjusted EBITDA" is defined by the Company as net income/(loss) adjusted for interest and finance charges, net income tax expense, foreign exchange gains/(losses), severance and other charges, stock-based compensation expense, other income/(expense), gain/(loss) on disposal of group of assets and exceptional items (including merger and integration costs), depreciation, amortization and impairments. Prior to the adjustments for the Coretrax acquisition, the Adjusted EBITDA targets were set at |
| (2) |
"Free Cash Flow" is defined by the Company as Adjusted Cash Flow From Operations (Adjusted CFFO, which excludes cash paid for interest and exceptional items, such as severance and other integration related costs, share repurchases, withholding taxes on vested shares, settlement costs/payments (e.g., FCPA), and M&A related costs) less Core Capital Expenditures (Core Capex, which excludes integration-related Capex, capitalized software and licenses, and M&A). Prior to the adjustments for the Coretrax acquisition, the Free Cash Flow targets were set at |
| (3) |
Total Recordable Case Frequency, or "TRCF", is defined as the total recordable cases multiplied by one million, divided by the number of exposure (working) hours. |
| (4) |
ESG component is measured by the total reduction measured in CO2e GHG ( |
As reflected in the table above, if the Company achieved the target performance metrics for 2024, the cash incentive awards for the Named Executive Officers would be paid at 100% of the target levels. Achievement of the threshold level would result in a 50% payout of a target cash incentive award and achievement of the maximum or greater performance level would result in a maximum payout of 200% of target. Performance below the threshold goal would result in no payout for that particular metric. While the Compensation Committee has discretion to adjust payments up and down, based on individual performance and other factors, no adjustments were made to any of our Named Executive Officers' individual annual incentive payments for 2024 under the plan.
For performance achievement between threshold, target, and maximum levels, payouts are calculated using straight line interpolation. The actual results attained by the Company during 2024 with respect to the performance metrics established for 2024 yielded a 55.25% payout. This was based on actual results as described in the table below.
|
Goal |
Weighting | Actual | Weighted Achievement (%) |
|||||||
|
Adjusted EBITDA |
50% |
|
40.25% |
|||||||
|
Free Cash Flow |
35% |
|
0% |
|||||||
|
TRCF |
10% |
1.05 |
10.0% |
|||||||
|
ESG |
5% |
3,537 tonnes |
5.0% |
|||||||
|
Total Payout % |
55.25% |
|||||||||
The amounts listed in the table below reflect the actual 2024 STI payout received by each of the Named Executive Officers based on the performance criteria described above.
|
|
Actual 2024 Incentive Award Payout ($) |
||||
|
|
$ |
690,625 |
|||
|
|
$ |
252,168 |
|||
|
|
$ |
292,383 |
|||
|
|
$ |
225,427 |
* |
||
|
|
$ |
238,419 |
|||
| * |
Converted to USD from GBP using an exchange ratio of |
|
26 | 2025 Proxy Statement |
COMPENSATION DISCUSSION AND ANALYSIS
Long-Term Incentives
Equity Awards
To create additional incentives for the executive officers to continue to grow enterprise value and to align their pay with shareholders, we maintain the Company's 2022 Long-Term Incentive Plan (the "LTIP"). We believe a formal long-term equity-based incentive program is important and consistent with the compensation programs of the companies in our peer group. We also believe that long-term equity-based incentive compensation is an important component of our overall compensation program because it:
| • |
balances short- and long-term objectives; |
| • |
aligns our executives' interests with the long-term interests of our shareholders; |
| • |
rewards long-term performance relative to industry peers; |
| • |
makes our compensation program competitive from a total remuneration standpoint; |
| • |
encourages executive retention; and |
| • |
gives executives the opportunity to share in our long-term value creation. |
Our Compensation Committee has the authority under the LTIP to award incentive equity compensation to our executive officers in such amounts and on such terms as the Compensation Committee determines appropriate in its sole discretion based on a variety of factors, including the Company's financial and operating performance; the size and mix of the executive's total compensation; achievement of strategic non-financialgoals; market comparisons and individual factors.
2024 Equity Awards
Our long-term equity-based incentive compensation consists of grants of performance-based restricted stock unit awards ("PRSU") and time-based restricted stock unit awards ("RSU"). In
PRSU / RSU mix
| • |
60% of the annual awards were provided in the form of PRSUs and 40% of annual awards were provided in the form of RSUs. |
Vesting Conditions
| • |
The time-based RSUs provide for ratable vesting with one-thirdvesting on |
| • |
The PRSUs granted in 2024 vest at the end of a three-year performance period ending on |
Key Award Conditions
| • |
RSUs and PRSUs are subject to the recipient's continuous employment at the Company. |
| • |
The PRSUs are subject to the achievement of performance conditions based on the Company's total shareholder retu("TSR") performance as compared to the TSR performance of the constituent companies in the exchange traded fund (ETF) described below, with payout determined as follows: |
|
(1) performance for the three-year performance period is measured by calculating TSR performance at the end of the entire period; (2) the Company's relative TSR is measured against the companies listed in the SPDR S&P Oil & |
|
2025 Proxy Statement | 27 |
COMPENSATION DISCUSSION AND ANALYSIS
(3) in determining payout amounts, the TSR relative percentile rank and the resulting payout percentages include the following levels, however, if TSR for the performance period is negative, the payout will not exceed 100% of the target level:
|
Level |
TSR Percentile Rank vs. |
Payout Percentage | ||||
|
Maximum |
90th percentile and above | 200% of Target Level | ||||
|
Target |
75th percentile | 150% of Target Level | ||||
|
Target |
50th percentile | 100% of Target Level | ||||
|
Threshold |
25th percentile | 50% of Target Level | ||||
| Below 25th percentile | 0% | |||||
Below is a summary of the value of LTIP awards made to each Named Executive Officer in 2024. The number of RSUs and PRSUs underlying each award is calculated using the 30-dayvolume-weighted average price of the Company's common stock. After reviewing market and peer group data, the Compensation Committee implemented increases to the total target LTIP awards for 2024, as compared to 2023, for each of the Named Executive Officers, as shown in the table below. There were no changes to the relative proportions of such awards that were granted as PRSUs versus RSUs, as compared to the LTIP awards granted in 2023.
|
|
2024 Target RSU (40%) |
2024 Target PRSU (60%) |
Total 2024 Target LTIP Award |
Percentage Increase in Total 2024 Target LTIP Award vs. 2023 |
||||||||||||||||
|
|
$ |
1,540,000 |
$ |
2,310,000 |
$ |
3,850,000 |
10% |
|||||||||||||
|
|
$ |
530,000 |
$ |
795,000 |
$ |
1,325,000 |
7% |
|||||||||||||
|
|
$ |
480,000 |
$ |
720,000 |
$ |
1,200,000 |
17% |
|||||||||||||
|
|
$ |
348,000 |
$ |
522,000 |
$ |
870,000 |
15% |
|||||||||||||
|
|
$ |
370,000 |
$ |
555,000 |
$ |
925,000 |
9% |
|||||||||||||
Vesting and Payout of Prior PRSUs
PRSUs previously granted to the Named Executive Officers in
All of the Named Executive Officers received grants of PRSUs in
|
|
TSR Percentile Payout Percentage |
|||
|
2022 performance period* |
0% |
|||
|
2023 performance period |
64% |
|||
|
2024 performance period |
0% |
|||
|
Final average |
21.3% |
|||
| * |
covers the period from |
Officers were not granted LTIP awards in 2022 due to the timing of this
|
28 | 2025 Proxy Statement |
COMPENSATION DISCUSSION AND ANALYSIS
Employee Stock Purchase Plan
We maintain the Company's 2023 Employee Stock Purchase Plan (the "ESPP"), which was approved by the Company's shareholders at the 2023 Annual Meeting in order to enable eligible employees (including the Named Executive Officers based in
Severance Benefits
Other than
CIC Severance Plan
Under the CIC Severance Plan, the Named Executive Officers who are participants in the plan are entitled to receive a cash severance equal to two times the sum of the executive's annual base salary and target annual incentive opportunity for the year of termination, as well as certain other severance benefits (including accelerated vesting of outstanding equity awards and a pro-ratedcash bonus based on their target incentive amount for the year of termination), upon a qualifying termination, which is defined as an involuntary termination within the 24-month periodfollowing a change in control. Other than
Executive Retention and Severance Plan
Under the Executive Retention and Severance Plan, the Named Executive Officers who are participants in the plan are entitled to receive severance in the amount of one times annual base salary, plus limited payments and reimbursements to cover outplacement assistance and health plan coverage, upon a qualifying termination of employment, which is defined as a termination by the Company without cause, or resignation by the executive for good reason. In order to prevent payment of benefits under both the CIC Severance Plan and the Executive Retention and Severance Plan, a termination in connection with a change in control entitling the executive to payment under the CIC Severance Plan cannot be a qualifying termination under the Executive Retention and Severance Plan. Other than
At the closing of the Merger, the Company and
|
2025 Proxy Statement | 29 |
COMPENSATION DISCUSSION AND ANALYSIS
Reason" (each such term as defined in the Jardon Agreement),
| • |
Cash severance equal to 2.0 times the sum of (i) the highest base salary in effect for |
| • |
Payment of any earned but unpaid annual bonus for the year immediately preceding the year in which the Termination Date occurs; |
| • |
A lump sum cash payment equal to |
| • |
Reimbursement of up to |
The Jardon Agreement further provides that if
| • |
Cash severance equal to 3.0 times the sum of (i) the highest base salary in effect for |
| • |
Payment of a pro-rataportion of the target annual bonus that would have been earned for the year in which the Termination Date occurs, based on the number of days employed during such year; |
| • |
A lump sum cash payment equal to |
| • |
Accelerated vesting of any outstanding equity awards, with vesting of any performance-based equity awards determined based on the greater of (x) actual performance as of the Termination Date and (y) target performance at the 100% target payout level; and |
| • |
Reimbursement of up to |
Other Arrangements
In addition, the Named Executive Officers may become entitled to continued or accelerated vesting under the terms of certain outstanding RSU and/or PRSU awards upon qualifying terminations of employment (subject to certain restrictive covenant obligations).
See "-Potential Payments upon Termination or a Change in Control," for a more detailed discussion of the payments and benefits provided under each of the arrangements noted above. We believe that these arrangements help to ensure the day-to-day stabilityand focus of our management team and are consistent with competitive practices.
Perquisites and Other Compensation Elements
The Company pays certain limited automobile expenses for each Messrs. Jardon, Fanning, McAlister and Geddes. Messrs. McAlister and Geddes, who participate in our
|
30 | 2025 Proxy Statement |
COMPENSATION DISCUSSION AND ANALYSIS
On
Risk Assessment
The Compensation Committee annually reviews the Company's compensation policies as generally applicable to employees and believes that these policies do not encourage excessive or unnecessary risk-taking and that the level of risk that they do encourage is not reasonably likely to have a material adverse effect on the Company. In addition, the following specific factors, in particular, reduce the likelihood of excessive risk-taking:
| • |
The Company's overall compensation levels are competitive with the market; |
| • |
The Company's compensation mix is balanced among (i) fixed components, like salary and benefits, (ii) annual incentives that reward the Company's overall financial and business performance, business unit financial performance, operational measures, and individual performance, and (iii) long-term incentives that align executives' interests with those of our shareholders, encouraging them to preserve long-term shareholder value and avoid excessive risks; |
| • |
Multiple performance metrics are used across the short- and long-term incentive program; |
| • |
Incentive programs have maximum payout limitations; |
| • |
Long-term incentive awards are granted on an annual basis, creating overlapping vesting and performance measurement periods, and ensuring that executives remain exposed to the risks of their decisions over time; |
| • |
Named Executive Officers are subject to stock ownership guidelines that require that they hold a minimum value of stock while employed by the Company; |
| • |
We have clawback provisions in key agreements, such as our RSU award agreements and the CIC Severance Plan, and our Named Executive Officers are also subject to our recoupment policies; and |
| • |
Our insider trading policy contains prohibitions against pledging and engaging in hedging transactions with respect to our stock and other securities. |
In summary, although a portion of the compensation provided to the Named Executive Officers may be based on the Company's performance and on the individual successes of the employee, the Company believes its compensation programs do not encourage excessive and unnecessary risk-taking by executive officers (or other employees) because these programs are designed to encourage employees to remain focused on both short- and long-term operational and financial goals of the Company. Additionally, our use of long-term equity-based compensation serves our compensation program's goal of aligning the interests of executives and shareholders, thereby reducing the incentives for unnecessary risk-taking. Facets of compensation that incentivize these executives but mitigate risk-taking have been and will continue to be one of the many factors considered by the Compensation Committee during its review of the Company's compensation programs and during the design of new programs that may become effective in connection with the Company's continued growth and development. In the future, the Compensation Committee will seek to ensure that any changes made to the compensation programs do not encourage excessive or unnecessary risk-taking and that any level of risk that they do encourage is not reasonably likely to have a material adverse effect on the Company.
Stock Ownership Guidelines
Our Named Executive Officers are subject to stock ownership guidelines that were established by our Board as of the closing of the Merger, and replaced a similar set of guidelines that had previously been established by the Company's then Supervisory Board prior to the Merger. These guidelines reinforce the importance of aligning the
|
2025 Proxy Statement | 31 |
COMPENSATION DISCUSSION AND ANALYSIS
interests of our executive officers with the interests of our shareholders. The current guidelines are expressed in terms of the value of our executive officers' equity holdings as a multiple of each currently employed executive officer's base salary, as follows:
|
Officer Level |
Ownership Guideline | |
|
President/Chief Executive Officer |
5x annualized base salary | |
|
Direct Reports to the CEO (that are executive officers) |
3x annualized base salary | |
|
All other direct reports to the CEO (other than the Executive Assistant) and the Principal Accounting Officer |
2x annualized base salary | |
These stock ownership levels must be achieved by each individual within 5 years of the later of
Equity interests that count toward the satisfaction of the ownership guidelines include stock owned directly by the employee or jointly owned, stock owned indirectly by the employee (e.g., by a spouse, by an immediate family member residing in the same household or in a trust for the benefit of the executive or his family), stock held under the officer's account under any company-sponsored retirement plan or under the Company's employee stock purchase plan, unvested (or vested but unsettled) time-based RSUs or restricted stock held by the officer granted pursuant to the Company's LTIP or any prior plan (but only to the extent required to be settled in shares of common stock), any non-restrictedshares granted to the officer pursuant to the LTIP or any prior plan, and any stock purchased by the officer in the open market. Unvested PRSUs do not count toward satisfaction of the ownership guidelines. During the five-year grace period for compliance, an individual may not sell any shares of common stock, except for personally-held shares or shares sold to meet expected tax obligations, until that individual's stock ownership level has been achieved. To the extent shares of common stock have been sold from vested RSUs granted by the Company, the equivalent amount of personally-held shares of common stock may not be sold unless the individual has satisfied the applicable ownership level. Pursuant to our stock ownership guidelines, ownership is calculated based on an individual's annual base salary and the greater of (i) the average closing price of a share of the Company's common stock over the previous calendar year or (ii) the value at acquisition. All of our Named Executive Officers are currently in compliance with the applicable requirements of our stock ownership guidelines or within the grace period contemplated thereby.
Additionally, we have stock ownership guidelines for our non-employeedirectors, requiring a minimum holding of 5x the annualized cash retainer. For information regarding these guidelines, please see "Director Compensation" below.
Recoupment Policy
We have adopted a Compensation Recovery Policy (the "Compensation Recovery Policy"), consistent with the requirements of the NYSE and Rule 10D-1of the Securities Exchange Act of 1934, as amended, as well as an additional Recoupment Policy (the "Recoupment Policy") which give the Company the right to recover incentive-based compensation previously paid to certain specified persons in certain situations such as misconduct.
|
32 | 2025 Proxy Statement |
COMPENSATION DISCUSSION AND ANALYSIS
A summary of certain key features of both policies is below, which summary is qualified in its entirety by the complete language of both policies. The Compensation Recovery Policy is an exhibit to our Annual Report on Form 10-Kfiled on
| Compensation Recovery Policy | Recoupment Policy | |||
|
Effective Date |
The Recoupment Policy replaces an earlier recoupment policy of the Company that applies prior to the Effective Date. |
|||
|
Persons Covered |
Current and former executive officers of the Company. | Any current or former employee of the Company, manager level or above, who received incentive-based compensation. | ||
|
Events Triggering Recovery Rights |
Restatement of any of the Company's financial statements due to the Company's material noncompliance with any financial reporting requirement under |
• a Restatement; or • a determination by the independent directors of the Company that the relevant employee has engaged in Misconduct*. |
||
|
Amount of Compensation Recoverable |
The amount of any incentive-based compensation that is in excess of such compensation that would have been received based on the Restatement (the "Excess Compensation") | In the event of a Restatement, any Excess Compensation. In the event of Misconduct, any and all incentive compensation received during the applicable recoupment period. | ||
|
Discretion Over Enforcement |
The Compensation Committee is required to seek recoupment of the Excess Compensation unless impracticable, as specifically defined in the policy. | Enforcement of the policy is at the sole discretion of the Compensation Committee. | ||
|
Recoupment Period |
Excess Compensation paid with respect to the three completed fiscal years prior to the earlier of (i) the date that the Board, a committee thereof or the officers of the Company conclude (or should have concluded) that a Restatement is required or (ii) the date a court, regulator or similar body orders the Company to undertake a Restatement. | Compensation granted within the 36-monthperiod preceding a Restatement or in the 36-monthperiod preceding and following any employee's Misconduct. | ||
| * |
"Misconduct" means that such person has (i) engaged in gross negligence, incompetence, or misconduct in the performance of the employee's duties with respect to the Company; (ii) has failed to materially perform his duties and responsibilities to the Company; (iii) has breached any written agreement with the Company; (iv) has breached any corporate policy or code of conduct established by the Company; (v) has engaged in conduct that is, or could reasonably expected to be, materially injurious to the Company, in terms of business operations, financial results, or reputation; (vi) has committed an act of theft, fraud, embezzlement, misappropriation, or breach of a fiduciary duty to the Company, or (vii) has been convicted of, pleaded no contest to, or received adjudicated probation or deferred adjudication in connection with a crime involving fraud, dishonesty, or moral turpitude or any felony (or a crime of similar import in a foreign jurisdiction). |
Equity Grant Timing Practices
The Compensation Committee approves all equity award grants to our Named Executive Officers on or before the grant date. Equity awards are generally made on a predetermined cycle in the first quarter of the fiscal year, though the Compensation Committee maintains discretion to grant additional equity awards outside of the annual grant cycle. The Compensation Committee does not have a practice or policy of granting equity awards in anticipation of the release of material non-publicinformation and, in any event, does not time the release of material non-publicinformation in coordination with grants of equity awards in a manner that intentionally benefits the Named Executive Officers or otherwise for the purpose of affecting the value of executive compensation. In fiscal 2024, equity compensation for our Named Executive Officers consisted solely of RSUs and PRSUs; we did not grant stock options in 2024.
Accounting and Tax Considerations
Section 162(m) of the Code limits the deductibility of certain compensation expenses in excess of
While the tax impact of any compensation arrangement is one factor to be considered, such impact is evaluated in light of the Company's overall compensation philosophy and objectives. The Company believes that maintaining the
|
2025 Proxy Statement | 33 |
COMPENSATION DISCUSSION AND ANALYSIS
discretion to evaluate the performance of executive officers is an important part of the Company's responsibilities and benefits public shareholders, and therefore, the Company may award compensation to the Named Executive Officers that is not fully deductible if it is determined that such compensation is consistent with the Company's compensation philosophy and benefits shareholders. Section 409A of the Code requires that "nonqualified deferred compensation" be deferred and paid under plans or arrangements that satisfy the requirements of the statute with respect to the timing of deferral elections, timing of payments, and certain other matters. Failure to satisfy these requirements can expose employees and other service providers to accelerated income tax liabilities and penalty taxes and interest on their vested compensation under such plans. Accordingly, as a general matter, it is the Company's intention to design and administer its compensation and benefits plans and arrangements for all employees and other service providers, including the executive officers, so that they are either exempt from, or satisfy the requirements of, section 409A of the Code.
Any equity awards granted to our employees, including executive officers, are reflected in the Company's consolidated financial statements, based upon the applicable accounting guidance, at fair market value on the grant date in accordance with
|
34 | 2025 Proxy Statement |
EXECUTIVE COMPENSATION
Summary Compensation Table
The table below sets forth the annual compensation earned by or granted by the Company to the Named Executive Officers during the 2024, 2023, and 2022 fiscal years. For an explanation of the compensation mix and the relative amounts of each compensation element, please see the "Components of the Company's Executive Compensation Program" section of our Compensation Discussion and Analysis above.
|
Name and Principal Position(1) |
Year |
Salary ($)(2) |
Bonus ($) |
Stock Awards ($)(3) |
Non-Equity Incentive Plan Compensation ($)(4) |
All Other Compensation ($)(5) |
Total ($) | ||||||||||||||||||||||||||||
|
President and Chief Executive Officer |
2024 | 1,000,000 | - | 5,246,072 | 690,625 | 25,800 | 6,962,497 | ||||||||||||||||||||||||||||
|
2023 |
1,000,000 |
- |
5,169,391 |
937,500 |
25,200 |
7,132,091 |
|||||||||||||||||||||||||||||
|
2022 |
1,000,000 |
- |
- |
1,117,500 |
430,819 |
2,548,319 |
|||||||||||||||||||||||||||||
|
Chief Financial Officer |
2024 | 456,412 | - | 1,805,471 | 252,168 | 25,800 | 2,539,851 | ||||||||||||||||||||||||||||
|
2023 |
450,000 |
- |
1,827,732 |
337,500 |
25,200 |
2,640,432 |
|||||||||||||||||||||||||||||
|
2022 |
450,000 |
- |
- |
402,300 |
78,075 |
930,375 |
|||||||||||||||||||||||||||||
|
Chief Operating Officer |
2024 | 529,200 | - | 1,635,131 | 292,383 | 384,985 | 2,841,699 | ||||||||||||||||||||||||||||
|
2023 |
527,265 |
- |
1,514,069 |
395,449 |
312,630 |
2,749,413 |
|||||||||||||||||||||||||||||
|
2022 |
520,726 |
- |
- |
465,529 |
114,491 |
1,100,746 |
|||||||||||||||||||||||||||||
|
General Counsel and Secretary |
2024 | 408,013 | - | 1,185,484 | 225,427 | 95,148 | 1,914,072 | ||||||||||||||||||||||||||||
|
2023 |
386,130 |
- |
1,121,100 |
289,597 |
89,629 |
1,886,456 |
|||||||||||||||||||||||||||||
|
2022 |
385,585 |
- |
- |
344,713 |
89,450 |
819,748 |
|||||||||||||||||||||||||||||
|
Chief Technology Officer |
2024 | 431,527 | - | 1,260,412 | 238,419 | 13,800 | 1,944,157 | ||||||||||||||||||||||||||||
|
2023 |
425,000 |
- |
1,255,419 |
318,750 |
13,200 |
2,012,369 |
|||||||||||||||||||||||||||||
|
2022 |
425,000 |
- |
- |
379,950 |
6,100 |
811,050 |
|||||||||||||||||||||||||||||
| (1) | Reflects positions as of |
| (2) | The salary amounts set forth do not reflect the annual rate of salary that is "set" for the year, but what is considered "earned" for that year and thus they may differ slightly from the stated base salary amounts due to normal payroll practices and mid-yearbase salary increases. For 2023, amounts for |
| (3) | The amounts reflected in this column for 2024 reflect equity grants of RSUs and PRSUs granted in 2024, the details of which are reflected in the "Components of the Company's Executive Compensation Program" section of our Compensation Discussion and Analysis above. All amounts reflected in this column represent the aggregate grant date fair value of the awards granted to the Named Executive Officers calculated pursuant to FASB ASC Topic 718, disregarding any potential forfeitures. With respect to PRSUs, the amount is also reflective of the "probable" outcome of vesting for accounting purposes. Please see Note 20 to our Consolidated Financial Statements for the 2024 fiscal year within our Form 10-K,filed with the |
| (4) | The amounts in this column for 2024 reflect combined short-term incentive awards approved for the Named Executive Officers, the details of which are as described under "Compensation Discussion and Analysis- Components of the Company's Executive Compensation Program-Annual Cash Incentives". Amounts for |
| (5) | The amounts reflected in this column for the last completed fiscal year include the specific items reflected in the All Other Compensation table below. |
|
2025 Proxy Statement | 35 |
EXECUTIVE COMPENSATION
All Other Compensation:
|
|
Allowance ( |
Automobile Expenses ($)(1) |
Employer 401(k) Match ($) |
Expat Allowances and Premiums ($)(3) |
Housing Allowance ($)(4) |
Other ( |
Total ($) |
||||||||||||||||||||||||||||
|
|
- |
12,000 |
13,800 |
- |
- |
- |
25,800 |
||||||||||||||||||||||||||||
|
|
- |
12,000 |
13,800 |
- |
- |
- |
25,800 |
||||||||||||||||||||||||||||
|
|
105,840 |
17,972 |
- |
127,008 |
119,826 |
14,339 |
384,985 |
||||||||||||||||||||||||||||
|
|
81,603 |
12,468 |
- |
- |
- |
1,077 |
95,148 |
||||||||||||||||||||||||||||
|
|
- |
- |
13,800 |
- |
- |
- |
13,800 |
||||||||||||||||||||||||||||
| (1) | Amounts for |
| (2) | Messrs. McAlister and Geddes each receive a cash allowance in lieu of pension participation in the Expro North Sea Limited Retirement and Death Benefits Plan. The cash allowance is equal to 20% of their respective base salaries. |
| (3) | Paid pursuant to the Service Contract entered into with |
| (4) | Amounts for |
| (5) | For |
Grants of Plan-Based Awards for 2024
|
Estimated Possible Payouts Under |
Estimated Future Payouts Under |
All Other |
Grant |
|||||||||||||||||||||||||||||||||||||||||
|
|
Type |
Grant Date |
Threshold ($) |
Target ($) |
Maximum ($) |
Threshold (#) |
Target (#) |
Maximum (#) |
||||||||||||||||||||||||||||||||||||
|
|
Cash (1) | n/a | 625,000 | 1,250,000 | 2,500,000 | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
| PRSU(2) | - | - | - | 67,465 | 134,930 | 269,860 | - | 3,508,180 | ||||||||||||||||||||||||||||||||||||
| RSU(3) | - | - | - | - | - | - | 89,953 | 1,737,892 | ||||||||||||||||||||||||||||||||||||
|
|
Cash (1) | n/a | 232,500 | 465,000 | 930,000 | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
| PRSU(2) | - | - | - | 23,219 | 46,437 | 92,874 | - | 1,207,362 | ||||||||||||||||||||||||||||||||||||
| RSU(3) | - | - | - | - | - | - | 30,958 | 598,109 | ||||||||||||||||||||||||||||||||||||
|
|
Cash (1) | n/a | 264,600 | 529,200 | 1,058,400 | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
| PRSU(2) | - | - | - | 21,028 | 42,056 | 84,112 | - | 1,093,456 | ||||||||||||||||||||||||||||||||||||
| RSU(3) | - | - | - | - | - | - | 28,037 | 541,675 | ||||||||||||||||||||||||||||||||||||
|
|
Cash (1) | n/a | 211,096 | 422,193 | 844,386 | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
| PRSU(2) | - | - | - | 15,246 | 30,491 | 60,982 | - | 792,766 | ||||||||||||||||||||||||||||||||||||
| RSU(3) | - | - | - | - | - | - | 20,327 | 392,718 | ||||||||||||||||||||||||||||||||||||
|
|
Cash (1) | n/a | 220,000 | 440,000 | 880,000 | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
| PRSU(2) | - | - | - | 16,209 | 32,418 | 64,836 | - | 842,868 | ||||||||||||||||||||||||||||||||||||
| RSU(3) | - | - | - | - | - | - | 21,612 | 417,544 | ||||||||||||||||||||||||||||||||||||
| (1) |
Represents cash awards under the Company's annual incentive program as described under "Compensation Discussion and Analysis- Components of the Company's Executive Compensation Program-Annual Cash Incentives". Amounts for |
|
36 | 2025 Proxy Statement |
EXECUTIVE COMPENSATION
| (2) |
Represents the potential number of shares payable under the performance-based restricted stock units (or PRSUs). Amounts reported (a) in the "Threshold" column reflect 50% of the target number of shares denominated under each Named Executive Officer's PRSU award, which, in accordance with |
| (3) |
Represents shares of restricted stock units subject to time-based vesting conditions. The terms of these grants are described under "Compensation Discussion and Analysis-Components of the Company's Executive Compensation Program-Long Term Incentives-Equity Awards." |
| (4) |
See Note 3 in the Summary Compensation Table above for information on the value of the RSUs (the "2024 RSUs") and PRSUs (the "2024 PRSUs") granted in 2024. |
Narrative Description to the Summary Compensation Table and the Grants of Plan-Based Awards Table for the 2024 Fiscal Year
Summary Compensation Table. As of the closing of the Merger, the Company entered into an employment agreement with
As of the closing of the Merger, the Company entered into an
Effective
As of the closing of the Merger, the Company entered into a Service Contract with
|
2025 Proxy Statement | 37 |
EXECUTIVE COMPENSATION
As of the closing of the Merger, the Company entered into an Employment Assignment Letter with
Grants of Plan Based Awards Table. The 2024 RSUs granted to Messrs. Jardon, Fanning, Geddes, McAlister and Russell are scheduled to vest ratably in three equal annual installments beginning on
The 2024 PRSUs granted to Messrs. Jardon, Fanning, Geddes, McAlister and Russell are scheduled to vest based on the applicable payout percentage as determined by the performance criteria for the three-year performance period ending
Outstanding Equity Awards at 2024 Fiscal Year End
The table below reflects each option and equity-based compensation award held by our Named Executive Officers as of
| Option Awards(1) | Stock Awards | |||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Number of securities underlying unexercised options (#) exercisable |
Number of securities underlying unexercised options (#) unexercisable |
Equity incentive plan awards: number of securities underlying unexercised unearned options (#) |
Option exercise price ($) |
Option expiration date |
Number of Shares or Units of Stock That Have Not Vested (#)(2) |
Market Value of Shares or Units of Stock That Have Not Vested ($)(3) |
Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#)(4) |
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Rights That Have Not Vested ($)(5) |
|||||||||||||||||||||||||||||||||||||||||
|
|
782,103 | - | - | 17.08 | 02/04/2028 | 176,049 | 2,195,331 | 413,444 | 5,155,647 | |||||||||||||||||||||||||||||||||||||||||
|
|
196,102 | - | - | 17.74 | 02/04/2028 | 70,800 | 882,876 | 130,400 | 1,626,088 | |||||||||||||||||||||||||||||||||||||||||
|
|
215,077 | - | - | 17.08 | 02/04/2028 | 62,668 | 781,470 | 114,865 | 1,432,367 | |||||||||||||||||||||||||||||||||||||||||
|
|
195,525 | - | - | 17.08 | 02/04/2028 | 43,608 | 543,792 | 79,680 | 993,610 | |||||||||||||||||||||||||||||||||||||||||
|
|
- | - | - | - | - | 44,447 | 554,254 | 81,028 | 1,010,419 | |||||||||||||||||||||||||||||||||||||||||
| (1) |
In connection with the Merger, the Company assumed the outstanding option awards of Legacy Expro, which were then adjusted in accordance with the Merger consideration. The options have vested pursuant to the internal rate of retuthresholds. |
| (2) |
This column reflects the number of shares of unvested restricted stock units (RSUs) held by each Named Executive Officer on |
| • |
In |
| • |
In |
| • |
In |
| (3) |
This column reflects the aggregate market value of all shares of unvested restricted stock units held by each Named Executive Officer on |
|
38 | 2025 Proxy Statement |
EXECUTIVE COMPENSATION
| (4) |
This column reflects the number of shares of unvested PRSUs held by each Named Executive Officer on |
| • |
In |
| • |
In |
| • |
In |
| (5) |
This column reflects the aggregate market value of all shares of unvested PRSUs held by each Named Executive Officer on |
Option Exercises and Stock Vested in Fiscal Year 2024
The following table provides information concerning equity awards of our Named Executive Officers that vested during the 2024 fiscal year. No stock options were exercised by our Named Executive Officers during the 2024 fiscal year.
| Stock Awards | ||||||||||
|
|
Number of Shares Acquired on Vesting (#) |
Value Realized on Vesting ($)(1) |
||||||||
|
|
61,892 |
1,180,746 |
||||||||
|
|
31,284 |
599,101 |
||||||||
|
|
27,543 |
527,735 |
||||||||
|
|
18,033 |
345,143 |
||||||||
|
|
31,669 |
608,200 |
||||||||
| (1) |
The amounts reflected in this column represent the aggregate market value realized by each Named Executive Officer upon vesting of the RSUs or PRSUs held by such Named Executive Officer, computed based on the closing price of our common stock on the last trading day prior to the applicable vesting date. |
Pension Benefits
In connection with the Merger, the Company assumed certain pension plans of Legacy Expro. None of the Named Executive Officers participate in any of the Company's pension plans. Consequently, no table is included herein.
Potential Payments Upon Termination or a Change in Control
Long Term Incentive Plan
The following discussion and the amounts disclosed in the table below are based on the terms of arrangements as in effect on
RSU Awards
The RSUs that were granted to the Named Executive Officers during 2021, 2023 and 2024 will receive accelerated vesting upon a termination of employment due to death or "Disability." For all Named Executive Officers other than
|
2025 Proxy Statement | 39 |
EXECUTIVE COMPENSATION
to the vesting schedule as if the executive were continuing in the employment of the Company throughout the period during which the executive continuously satisfies certain non-competition and non-solicitation obligations.As defined in the RSU award agreements, each of the terms have the following meaning:
| • |
"Disability" means the executive's inability to perform his or her duties or fulfil his or her obligations under the terms of his employment by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than six months as determined by the Company and certified in writing by a competent medical physician selected by the Company. |
| • |
A "Change in Control" is generally defined in our former long term incentive plan (which applies to the RSUs granted in 2021) as one of the following events: (i) the consummation of an agreement to acquire, or a tender offer for beneficial ownership of, 50% or more of either the then outstanding shares of common stock, or the combined voting securities that are entitled to vote in the election of directors; (ii) individuals who are on our board of directors on the effective date of our former long term incentive plan or any individuals whose election or appointment was approved by a majority of the board of directors as of that date (the "Incumbent Board") cease to constitute a majority of the members of the board; (iii) a reorganization, merger or consolidation or sale or other disposition of all or substantially all of our assets, unless following such transaction, (a) our outstanding common stock or voting securities are converted into or exchanged for securities which represent more than 50% of the then outstanding shares of securities of the entity resulting from the transaction, (b) no person beneficially owns 20% or more of the then outstanding securities of the entity resulting from the transaction, or (c) at least a majority of the members of the board of directors or similar governing body of the entity resulting from the transaction were members of the Incumbent Board at the time of the execution of the agreement leading to the transaction; or (iv) our shareholders approve our complete liquidation or dissolution. |
| • |
A "Change in Control" is generally defined in our current LTIP (which applies to the RSUs granted in 2023 and 2024) as one of the following events: (i) the acquisition of beneficial ownership of, 50% or more of either the then outstanding shares of common stock, or the combined voting securities that are entitled to vote in the election of directors; (ii) individuals who are on our board of directors on the effective date of our LTIP or any individuals whose election or appointment was approved by a majority of the board of directors as of that date (the "Incumbent Board") cease to constitute a majority of the members of the board; (iii) a reorganization, merger or consolidation or sale or other disposition of all or substantially all of our assets, unless following such transaction, (a) our outstanding common stock or voting securities are converted into or exchanged for securities which represent more than 50% of the then outstanding shares of securities of the entity resulting from the transaction, or (b) at least a majority of the members of the board of directors or similar governing body of the entity resulting from the transaction were members of the Incumbent Board at the time of the execution of the agreement leading to the transaction; or (iv) our shareholders approve our complete liquidation or dissolution. |
| • |
An "Involuntary Termination" means a termination of employment by the Company or an affiliate without Cause. |
| • |
"Cause" shall generally mean that the executive (i) has engaged in gross negligence, gross incompetence, or misconduct in the performance of his or her duties; (ii) has failed without proper legal reason to perform his or her duties and responsibilities; (iii) has breached any material provision of the award agreement or any written agreement or corporate policy or code of conduct established by the Company; (iv) has engaged in conduct that is, or could reasonably expected to be, materially injurious to the Company; (v) has committed an act of theft, fraud, embezzlement, misappropriation, or breach of a fiduciary duty to the Company; or (vi) has been convicted of, pleaded no contest to, or received adjudicated probation or deferred adjudication in connection with a crime involving fraud, dishonesty, or moral turpitude or any felony (or a crime of similar import in a foreign jurisdiction). |
PRSU Awards
The PRSUs that were granted to the Named Executive Officers during 2021, 2023 and 2024 will receive accelerated vesting at the "target" level upon a termination of employment due to death or Disability. For all Named Executive Officers other than
|
40 | 2025 Proxy Statement |
EXECUTIVE COMPENSATION
the period during which the executive continuously satisfies certain non-competitionand non-solicitationobligations. As defined in the PRSU award agreements, each of the terms referenced herein have the same meaning described above with respect to the 2021, 2023 and 2024 RSU awards.
Upon a qualifying termination of
Executive Change-In-Control SeverancePlan
In 2024, all Named Executive Officers other than
| • |
Two times the sum of the "Base Salary" and "Target Bonus Amount," (as such terms are defined in the CIC Severance Plan), to be paid in equal monthly instalments over ten months; |
| • |
A lump sum cash payment of |
| • |
A lump sum cash amount equal to the executive's target annual incentive opportunity for the year of termination, pro-ratedthrough and including the date of termination; |
| • |
Accelerated vesting of any outstanding equity-based awards, with vesting of PRSUs determined based on the greater of actual performance through the date of termination or target performance at the 100% payout level; and |
| • |
Outplacement assistance benefits, as provided in each individual participation agreement. |
The following definitions apply to the CIC Severance Plan:
| • |
"Cause" means a determination by the Company or the employing affiliate (the "Employer") that the executive (i) has engaged in gross negligence, incompetence, or misconduct in the performance of his or her duties with respect to the Employer or any of its affiliates; (ii) has failed to materially perform the executive's duties and responsibilities to the Employer or any of its affiliates; (iii) has breached any material provision of the CIC Severance Plan or the accompanying Participation Agreement or any written agreement or corporate policy or code of conduct established by the Employer or any of its affiliates; (iv) has engaged in conduct that is, or could reasonably expected to be, materially injurious to the Employer or any of its affiliates; (v) has committed an act of theft, fraud, embezzlement, misappropriation, or breach of a fiduciary duty to the Employer or any of its affiliates; or (vi) has been convicted of, pleaded no contest to, or received adjudicated probation or deferred adjudication in connection with a crime involving fraud, dishonesty, or moral turpitude or any felony (or a crime of similar import in a foreign jurisdiction). |
| • |
"Change in Control" or "CIC" has the meaning given such term under the LTIP or our former long term incentive plan, as applicable (as discussed under "RSU Awards" above). |
| • |
"Good Reason" means the occurrence, on or within 24 months after the date upon which a CIC occurs, of any one or more of the following: (i) a material reduction in the authority, duties, or responsibilities of a covered executive from those applicable to him immediately prior to the date on which the CIC occurs; (ii) a material reduction in a covered executive's annual rate of base salary or target annual bonus opportunity in effect immediately prior to the CIC; (iii) a change in the location of a covered executive's principal place of employment by more than 50 miles from the location where he was principally employed immediately prior to the date on which the CIC occurs unless such relocation is agreed to in writing by the covered executive; provided, however, that a relocation scheduled prior to the date of the CIC shall not constitute Good Reason; (iv) any material breach by the Company or the Employer of their obligations under the CIC Severance Plan; (v) the failure of any successor or assigns of the Company and/or the Employer to assume the obligations of the Company and the Employer under the CIC Severance Plan; or (vi) the receipt of a written notice, within the 24-monthperiod following a CIC, of termination of the CIC Severance Plan or of any amendment that would adversely reduce the covered executive's potential severance payments or benefits or his or her coverage under the CIC Severance Plan. |
|
2025 Proxy Statement | 41 |
EXECUTIVE COMPENSATION
| • |
"Involuntary Termination" means any termination of the covered executive's employment with the Employer that is either a termination by the Employer other than for Cause or a termination by the covered executive for Good Reason; provided, however, that it shall not include any termination occurring as a result of the covered executive's death or a disability under circumstances entitling him to disability benefits under the standard long-term disability plan of the Employer. |
Executive Retention and Severance Plan
In 2024, all Named Executive Officers other than
| • |
A lump sum cash payment equal to one year of "base salary" (as such term is defined in the plan), to be paid in equal monthly instalments over ten months; |
| • |
A lump sum cash payment of |
| • |
If the covered executive's employment is terminated prior to payment of the "annual bonus" (as such term is defined in the plan) for the prior calendar year, the covered executive will receive an "annual bonus" at the same time as bonus payments are made to similarly situated employees under the Company's bonus plan; and |
| • |
Reimbursement of up to |
The following definitions apply to the Executive Retention and Severance Plan:
| • |
"Annual Bonus" means the annual bonus paid pursuant to the Frank's |
| • |
"Cause" shall mean a determination by the Company or the Employer that the Covered Employee (i) has engaged in gross negligence, incompetence, or misconduct in the performance of his or her duties with respect to the Employer or any of its affiliates; (ii) has failed to materially perform the Covered Employee's duties and responsibilities to the Employer or any of its affiliates; (iii) has breached any material provision of this Plan or the Participation Agreement or any written agreement or corporate policy or code of conduct established by the Employer or any of its affiliates; (iv) has engaged in conduct that is, or could reasonably expected to be, materially injurious to the Employer or any of its affiliates; (v) has committed an act of theft, fraud, embezzlement, misappropriation, or breach of a fiduciary duty to the Employer or any of its affiliates; or (vi) has been convicted of, pleaded no contest to, or received adjudicated probation or deferred adjudication in connection with a crime involving fraud, dishonesty, or moral turpitude or any felony (or a crime of similar import in a foreign jurisdiction). |
| • |
"Good Reason" means the occurrence of any one or more of the following: (a) a material reduction in a Covered Employee's annual rate of Base Salary; (b) a change in the location of a Covered Employee's principal place of employment by more than 50 miles from the location where he or she was principally employed, unless such relocation is agreed to in writing by the Covered Employee: (c) any material breach by the Company or the Employer of their obligations under this Plan; or (d) the failure of any successor or assigns of the Company and/or the Employer, as applicable, to assume the obligations of the Company and the Employer under this Plan. Notwithstanding the foregoing provisions of this Section or any other provision in this Plan to the contrary, any assertion by a Covered Employee of a termination of employment for "Good Reason" shall not be effective unless all of the following conditions are satisfied: (i) the condition described in the foregoing clauses of this Section giving rise to the Covered Employee's termination of employment must have arisen without the Covered Employee's consent; (ii) the Covered Employee must provide written notice to the Employer of such condition in accordance with the Notice Section of this Plan within 45 days of the initial existence of the condition; (iii) the condition specified in such notice must remain uncorrected for 30 days after receipt of such notice by the Employer; and the date of the Covered Employee's termination of employment must occur within 90 days after the initial existence of the condition specified in such notice. |
| • |
"Qualifying Termination" means a Qualifying Termination of the Covered Employee's employment with the Employer which is either: (i) a Separation from Service by the Employer other than for Cause; or (ii) a Separation from Service by the Covered Employee for Good Reason; provided, however, that the term "Qualifying Termination" shall not include any termination occurring as a result of (a) the Covered Employee's death or a |
|
42 | 2025 Proxy Statement |
EXECUTIVE COMPENSATION
| disability under circumstances entitling him or her to disability benefits under the standard long-term disability plan of the Employer; or (b) the Covered Employee's termination in connection with a change in control entitling him or her to severance benefits under the CIC Plan. |
| • |
"Separation Date" for purposes of this Plan means the date designated by the Administrator on which the Covered Employee's employment is terminated. |
| • |
"Separation from Service" shall have the same meaning as the term "separation from service" in Code Section 409A(a)(2)(A)(i) |
Employment Agreement with
| • |
Cash severance equal to 2.0 times the sum of (i) the highest base salary in effect for |
| • |
Payment of any earned but unpaid annual bonus for the year immediately preceding the year in which the Termination Date occurs; |
| • |
A lump sum cash payment equal to |
| • |
Reimbursement of up to |
The Employment Agreement further provides that if
| • |
Cash severance equal to 3.0 times the sum of (i) the highest base salary in effect for |
| • |
Payment of a pro-rataportion of the target annual bonus that would have been earned for the year in which the Termination Date occurs, based on the number of days employed during such year; |
| • |
A lump sum cash payment equal to |
| • |
Accelerated vesting of any outstanding equity awards, with vesting of any performance-based equity awards determined based on the greater of (x) actual performance as of the Termination Date and (y) target performance at the 100% target payout level; and |
| • |
Reimbursement of up to |
The following definitions apply to
| • |
"Cause" means |
|
2025 Proxy Statement | 43 |
EXECUTIVE COMPENSATION
| injurious to any member of the Company group; (e) has committed an act of theft, fraud, embezzlement, misappropriation, or breach of a fiduciary duty to any member of the Company group; or (f) has been convicted of, pleaded no contest to, or received adjudicated probation or deferred adjudication in connection with a crime involving fraud, dishonesty, or moral turpitude or any felony (or a crime of similar import in a foreign jurisdiction). |
| • |
"Change in Control" means the occurrence of any of the following events, excluding for the avoidance of doubt the transaction contemplated by the Merger Agreement: |
(A) the consummation of an agreement to acquire, or a tender offer for beneficial ownership (within the meaning of Rule 13d-3 promulgatedunder the Securities Exchange Act of 1934, as amended) by any person of, 50% or more of either (x) the then outstanding shares of common stock of the Company (the "Outstanding Stock") or (y) the combined voting power of the then outstanding voting securities of The Company entitled to vote generally in the election of directors (the "
(B) individuals who constitute the Incumbent Board cease for any reason to constitute at least a majority of the Board;
(C) consummation of a reorganization, merger, or consolidation or sale or other disposition of all or substantially all of the assets of the Company, or an acquisition of assets of another entity (a "Business Combination"), in each case, unless, following such Business Combination, (i) the
(D) approval by the stockholders of the Company of a complete liquidation or dissolution of the Company.
| • |
"Good Reason" means the occurrence of any of the following events: (a) a material reduction in |
| • |
"Incumbent Board" means the portion of the Board constituted of the individuals who are members of the Board as of the closing of the Merger and any other individual who becomes a director of the Board after the closing of the Merger and whose election or appointment by the Board or nomination for election by the Company's stockholders was approved by a vote of at least a majority of the directors then comprising the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Incumbent Board. |
|
44 | 2025 Proxy Statement |
EXECUTIVE COMPENSATION
Potential Payments Upon Termination or Change in Control for Remaining Named Executive Officers
The following table quantifies the potential payments and benefits that the Company would provide to its Named Executive Officers in connection with a termination of employment and/or change in control occurring on
|
Executive |
Involuntary Termination of Employment ($) |
Termination of ($) |
Termination of Employment by Retirement ($) |
Change in Control or Liquidity Event (Without a Termination of Employment) ($) |
Change in Control (With an Involuntary Termination) ($) |
||||||||||||||||||||
|
|
|||||||||||||||||||||||||
|
Cash Payments |
4,055,000 | - | - | - | 8,000,000 | ||||||||||||||||||||
|
Accelerated Equity(1) |
- | 7,350,978 | - | - | 7,350,978 | ||||||||||||||||||||
|
Reimbursement of COBRA Premiums |
12,500 | - | - | - | 22,500 | ||||||||||||||||||||
|
Outplacement Assistance |
7,500 | - | - | - | 15,000 | ||||||||||||||||||||
|
Total |
4,075,000 | 7,350,978 | - | - | 15,388,478 | ||||||||||||||||||||
|
|
|||||||||||||||||||||||||
|
Cash Payments |
465,000 | - | - | - | 2,325,000 | ||||||||||||||||||||
|
Accelerated Equity(1) |
- | 2,508,964 | - | - | 2,508,964 | ||||||||||||||||||||
|
Reimbursement of COBRA Premiums |
12,500 | - | - | - | 22,500 | ||||||||||||||||||||
|
Outplacement Assistance |
7,500 | - | - | - | 15,000 | ||||||||||||||||||||
|
Total |
485,000 | 2,508,964 | - | - | 4,871,464 | ||||||||||||||||||||
|
|
|||||||||||||||||||||||||
|
Cash Payments |
529,200 | - | - | - | 2,646,000 | ||||||||||||||||||||
|
Accelerated Equity(1) |
- | 2,213,837 | - | - | 2,213,837 | ||||||||||||||||||||
|
Reimbursement of COBRA Premiums |
12,500 | - | - | - | 22,500 | ||||||||||||||||||||
|
Outplacement Assistance |
7,500 | - | - | - | 15,000 | ||||||||||||||||||||
|
Total |
549,200 | 2,213,837 | - | - | 4,897,367 | ||||||||||||||||||||
|
|
|||||||||||||||||||||||||
|
Cash Payments |
422,193 | - | - | - | 2,110,965 | (2) | |||||||||||||||||||
|
Accelerated Equity(1) |
- | 1,537,401 | - | - | 1,537,401 | ||||||||||||||||||||
|
Reimbursement of COBRA Premiums |
12,500 | - | - | - | 22,500 | ||||||||||||||||||||
|
Outplacement Assistance |
7,500 | - | - | - | 15,000 | ||||||||||||||||||||
|
Total |
442,193 | 1,537,401 | 3,685,866 | ||||||||||||||||||||||
|
|
|||||||||||||||||||||||||
|
Cash Payments |
440,000 | - | - | - | 2,220,000 | ||||||||||||||||||||
|
Accelerated Equity(1) |
- | 1,564,673 | - | - | 1,564,673 | ||||||||||||||||||||
|
Reimbursement of COBRA Premiums |
12,500 | - | - | - | 22,500 | ||||||||||||||||||||
|
Outplacement Assistance |
7,500 | - | - | - | 15,000 | ||||||||||||||||||||
|
Total |
460,000 | 1,564,673 | - | - | 3,802,173 | ||||||||||||||||||||
| (1) |
|
| (2) |
Converted to USD from GBP using an exchange ratio of |
|
2025 Proxy Statement | 45 |
EXECUTIVE COMPENSATION
Director Compensation
In accordance with Dutch law and the Company's Articles, the shareholders shall determine the compensation policy of the Board. The Company's remuneration policy was previously adopted by the shareholders. The authority to establish the actual compensation for the members of the Board is vested in the Board, with due observance of the compensation policy.
The Board believes that attracting and retaining qualified non-employeedirectors is critical to the Company's future value, growth, and governance. The Board also believes that the compensation package for the Company's non-employeedirectors should require a portion of the total compensation to be equity-based to align the interests of these directors with the Company's stockholders. The Company, along with Meridian, has determined that the compensation program applicable to the non-employeedirectors should be comparable with the packages identified at the Company's peer group.
For 2024, the Board received the following remuneration: (i) an annual retainer compensation package for the non-executivedirectors valued at approximately
Our directors are subject to Stock Ownership Guidelines, which require our non-employeedirectors to hold shares of our common stock with a value equal to five times the amount of annual cash retainer (which does not include any extra fees for chairmanships or service on committees) paid to such directors. Our non-employeedirectors are required to achieve this stock ownership guideline within five years following the later of the date the guidelines became effective at the closing of the Merger or the date that the director was elected to our Board. Holdings that count towards satisfaction of this guideline, and the valuation measures used to determine such satisfaction, are the same that apply to our Named Executive Officers, as described in the section of our CD&A entitled, "-Stock Ownership Guidelines," above.
The following table reflects information concerning the compensation that the Company's non-employeedirectors earned during the last completed fiscal year ended December 31, 2024. Directors who are also employees of the Company do not receive any additional compensation for their service on the Board.
2024 Director Compensation
|
|
Fees Earned or Paid in Cash ($)(1) |
Stock Awards ($)(2) |
All Other Compensation ($) |
Total ($) | ||||||||||||||||
|
|
143,156 |
170,069 |
- |
313,225 |
||||||||||||||||
|
|
82,500 |
170,069 |
- |
252,569 |
|
|||||||||||||||
|
|
114,071 |
170,069 |
- |
284,140 |
||||||||||||||||
|
|
29,303 |
- |
- |
29,303 |
||||||||||||||||
|
|
105,000 |
170,069 |
- |
275,069 |
||||||||||||||||
|
|
97,500 |
170,069 |
- |
267,569 |
||||||||||||||||
|
|
87,500 |
170,069 |
- |
257,569 |
||||||||||||||||
|
|
95,000 |
170,069 |
- |
265,069 |
||||||||||||||||
|
46 | 2025 Proxy Statement |
EXECUTIVE COMPENSATION
| (1) |
Includes an annual cash retainer fee, and if applicable, committee, committee chair or non-executivechairman, all as described above and prorated for periods of partial service in such capacities during 2024. The below summarizes the components of each director's cash compensation as disclosed above: |
|
|
Annual Cash Retainer Fee ($) |
Committee Membership or Chair Fee ($) |
Board Chairman / Lead Director Fees ($) |
||||||||||||
|
|
75,000 |
7,500 |
60,656 |
||||||||||||
|
|
75,000 |
7,500 |
- |
||||||||||||
|
|
75,000 |
- |
39,071 |
||||||||||||
|
|
29,303 |
- |
- |
||||||||||||
|
|
75,000 |
30,000 |
- |
||||||||||||
|
|
75,000 |
22,500 |
- |
||||||||||||
|
|
75,000 |
12,500 |
- |
||||||||||||
|
|
75,000 |
20,000 |
- |
||||||||||||
| (2) |
The amounts reflected in this column are the aggregate grant date fair value of the RSUs granted to the non-employeedirectors during 2024 and calculated pursuant to ASC FASB Topic 718, disregarding any potential forfeitures. Please see Note 20 to our Consolidated Financial Statements for the 2024 fiscal year within our Form 10-K,filed with the |
|
The grants were made to all non-employeedirectors on June 1, 2024, in each case for 7,748 RSUs with a grant date fair value of $170,069. |
| (3) |
Messrs. Arbeter and Schrager have instructed that each of their cash retainer should be paid to their employer, |
| (4) |
|
CEO Pay Ratio Disclosures
As required by Section 953(b) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(u) of Regulation S-K,we are providing the following information about the relationship of the annual total compensation of our employees and the total compensation of
For 2024, our last completed fiscal year:
| • |
The median of the annual total compensation of all employees of our company (other than the CEO) was $32,206; and |
| • |
The annual total compensation of our CEO, using 2024 compensation data from the Summary Compensation Table, was $6,962,497. |
Based on this information, for 2024 the ratio of the annual total compensation of our CEO to the median of the annual total compensation of all employees was reasonably estimated to be 216.2 to 1.
The median employee that was used for purposes of calculating the ratio of the annual total compensation of our CEO to the median of the annual total compensation of all employees is the same employee that was identified for purposes of our 2023 disclosure. Our employee population data described above does not include approximately 333 employees of Coretrax, which we acquired in May 2024. There has otherwise been no change in our employee population or employee compensation arrangements since that median employee was identified that we believe would significantly impact our pay ratio disclosure.
| • |
We determined that, as of December 31, 2024, our employee population world-wide consisted of approximately 7,004 individuals. As of December 31, 2024, we had 1,152 employees in |
|
2025 Proxy Statement | 47 |
EXECUTIVE COMPENSATION
| • |
We used a consistently applied compensation measure to identify our median employee of comparing the amount of salary or wages, bonuses and any other cash compensation reflected in our payroll records as reported to the |
| • |
We identified our median employee by consistently applying this compensation measure to all of our employees included in our assumptions, adjustments (including any cost-of-livingadjustments), or estimates were applied to this calculation. |
| • |
After we identified our median employee, we combined all of the elements of such employee's compensation for the 2024 year in accordance with the requirements of Item 402(c)(2)(x) of Regulation S-K,resulting in annual total compensation of $32,206. |
| • |
With respect to the total compensation of our CEO, we used the amount reported in the "Total" column (column (j)) of our 2024 Summary Compensation Table included in this Proxy Statement and incorporated by reference under Item 11 of Part III of our Annual Report, which resulted in annual total compensation for purposes of determining the ratio in the amount of $6,962,497 for 2024. |
|
48 | 2025 Proxy Statement |
are providing the following information regarding the relationship between executive compensation and our financial performance for each of the last four completed fiscal years. The table below summarizes compensation values both previously reported in our Summary Compensation Table, as well as the adjusted values required in this section for the applicable years. Note that for our Named Executive Officers (each an "NEO") other than our principal executive officer (the "PEO"), compensation is reported as an average.
|
Year
|
Summary
Compensation Table Total for First PEO(1) |
Summary
Compensation Table Total for Second PEO(1) |
Compensation
Actually Paid to First PEO(1) |
Compensation
Actually Paid to Second PEO(1) |
Average
Summary Compensation Table Total for Non-CEO
NEOs(1) |
Average
Compensation Actually Paid to Non-CEO
NEOs(1)(2) |
Value of Initial Fixed
$100 Investment Based On: |
Net Income
(Loss) (in thousands) |
Adjusted
EBITDA (in thousands) |
|||||||||||||||||||||||||||||||
|
Total
Shareholder Return |
Total Shareholder Return |
|||||||||||||||||||||||||||||||||||||||
|
2024
|
N/A
|
6,962,497
|
N/A
|
1,775,784
|
2,309,945
|
960,713
|
40.20
|
103.72
|
51,918
|
347,403
|
||||||||||||||||||||||||||||||
|
2023
|
N/A
|
7,132,091
|
N/A
|
1,904,420
|
2,322,168
|
1,158,681
|
51.45
|
109.63
|
(23,360
|
)
|
248,880
|
|||||||||||||||||||||||||||||
|
2022
|
N/A
|
2,548,319
|
N/A
|
1,886,664
|
915,480
|
899,231
|
58.45
|
102.76
|
(20,145
|
)
|
206,233
|
|||||||||||||||||||||||||||||
|
2021
|
7,234,574
|
8,123,233
|
8,207,367
|
16,199,112
|
2,713,792
|
3,627,261
|
46.26
|
63.42
|
(131,891
|
)
|
125,940
|
|||||||||||||||||||||||||||||
|
2020
|
3,973,463
|
N/A
|
736,558
|
N/A
|
880,505
|
641,151
|
53.00
|
56.62
|
(307,045
|
)
|
100,186
|
|||||||||||||||||||||||||||||
|
(1)
|
The PEO and the
non-PEO
NEOs for each year are as follows: |
|
(i)
|
2024, 2023 and 2022:
|
|
(ii)
|
2021:
NEOs
|
|
(iii)
|
2020:
|
|
(2)
|
To calculate Compensation Actually Paid ("CAP"), the following amounts were deducted from and added to Summary Compensation Table ("SCT") total compensation:
|
|
Year
|
Salary
|
Bonus and
Non-Equity
Incentive |
Other
Compensation |
SCT
Total
|
Deductions
from SCT Total |
Additions
to SCT Total |
CAP
|
|||||||||||||||||||||
|
(i)
|
(ii)
|
(iii)
|
||||||||||||||||||||||||||
|
2024
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
|||||||||||||||||||||
|
2023
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
|||||||||||||||||||||
|
2022
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
|||||||||||||||||||||
|
2021
|
471,765
|
-
|
3,643,750
|
7,234,574
|
(3,119,059
|
)
|
4,091,852
|
8,207,367
|
||||||||||||||||||||
|
2020
|
709,637
|
354,825
|
12,825
|
3,973,463
|
(2,896,176
|
)
|
(340,729
|
)
|
736,558
|
|||||||||||||||||||
|
Year
|
Salary
|
Bonus and
Non-Equity
Incentive |
Other
Compensation |
SCT
Total |
Deductions
from SCT Total |
Additions
to SCT Total |
CAP
|
|||||||||||||||||||||
|
(i)
|
(ii)
|
(iii)
|
||||||||||||||||||||||||||
|
2024
|
1,000,000
|
690,625
|
25,800
|
6,962,497
|
(5,246,072
|
)
|
59,359
|
1,775,784
|
||||||||||||||||||||
|
2023
|
1,000,000
|
937,500
|
25,200
|
7,132,091
|
(5,169,391
|
)
|
(58,280
|
)
|
1,904,420
|
|||||||||||||||||||
|
2022
|
1,000,000
|
1,117,500
|
430,819
|
2,548,319
|
-
|
(661,655
|
)
|
1,886,664
|
||||||||||||||||||||
|
2021
|
1,149,618
|
1,008,900
|
12,000
|
8,123,233
|
(5,952,714
|
)
|
14,028,593
|
16,199,112
|
||||||||||||||||||||
|
2020
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
|||||||||||||||||||||
|
2025 Proxy Statement
|
49
|
NEOs SCT Total to CAP Reconciliation
|
Year
|
Salary
|
Bonus and
Non-Equity
Incentive |
Other
Compensation |
SCT
Total |
Deductions
from SCT Total |
Additions
to SCT Total |
CAP
|
|||||||||||||||||||||
|
(i)
|
(ii)
|
(iii)
|
||||||||||||||||||||||||||
|
2024
|
456,288
|
252,099
|
129,933
|
2,309,945
|
(1,471,625
|
)
|
122,393
|
960,713
|
||||||||||||||||||||
|
2023
|
447,099
|
335,324
|
110,165
|
2,322,168
|
(1,429,580
|
)
|
266,093
|
1,158,681
|
||||||||||||||||||||
|
2022
|
445,328
|
398,123
|
72,029
|
915,480
|
-
|
(16,248
|
)
|
899,231
|
||||||||||||||||||||
|
2021
|
406,922
|
242,138
|
634,634
|
2,713,792
|
(1,430,265
|
)
|
2,343,734
|
3,627,261
|
||||||||||||||||||||
|
2020
|
345,357
|
151,244
|
5,332
|
880,505
|
(378,573
|
)
|
139,219
|
641,151
|
||||||||||||||||||||
|
(i)
|
Reflects "all other compensation" reported in the SCT for each year shown.
|
|
(ii)
|
Represents the grant date fair value of equity-based awards granted each year. We did not report a change in pension value for any of the years reflected in this table; therefore, a deduction from SCT total related to pension value is not needed.
|
|
(iii)
|
Reflects the value of equity calculated in accordance with the
|
|
Equity Type
|
Fair Value
of Current Year Equity Awards at 12/31/2024 |
Change in
Value of Prior Years' Awards Unvested at 12/31/2024 |
Change
in Value of Prior Years' Awards That Vested in FY 2024 |
Fair Value
of Prior Years' Awards Forfeited in FY 2024 |
Equity
Value Included in CAP |
|||||||||||||||
|
Second PEO (Jardon)
|
2,713,547
|
(2,834,539)
|
180,351
|
-
|
59,359
|
|||||||||||||||
|
Average
Non-PEO
NEOs |
761,202
|
(718,730)
|
79,920
|
-
|
122,393
|
|||||||||||||||
|
(3)
|
The peer group used for total shareholder retuis
|
performance measures under its annual cash incentive program. For a description of the Company's PRSU grants, see page 27 and for a description of the Company's annual cash incentive program, see page 25.
|
Important Performance Measures for 2024
|
|
TSR
|
|
Adjusted EBITDA
|
|
Free Cash Flow
|
|
Total Recordable Case Frequency
|
|
ESG
|
|
50
|
2025 Proxy Statement
|
|
Compensation Actually Paid Versus TSR ($)
|
||||||||||||||||||||
|
12/31/20
|
12/31/21
|
12/31/22
|
12/31/23
|
12/31/24
|
||||||||||||||||
|
Compensation Actually Paid to First PEO
|
736,558
|
8,207,367
|
-
|
-
|
-
|
|||||||||||||||
|
Compensation Actually Paid to Second PEO
|
-
|
16,199,112
|
1,886,664
|
1,904,420
|
1,775,784
|
|||||||||||||||
|
Average Compensation Actually Paid to
Non-PEO
NEOs |
641,151
|
3,627,261
|
899,231
|
1,158,681
|
960,713
|
|||||||||||||||
|
TSR
|
53.00
|
46.26
|
58.45
|
51.45
|
40.20
|
|||||||||||||||
|
Peer Group TSR
|
56.62
|
63.42
|
102.76
|
109.63
|
103.72
|
|||||||||||||||
|
2025 Proxy Statement
|
51
|
|
Compensation Actually Paid Versus Net Income (Loss) ($)
|
||||||||||||||||||||
|
12/31/20
|
12/31/21
|
12/31/22
|
12/31/23
|
12/31/24
|
||||||||||||||||
|
Compensation Actually Paid to First PEO
|
736,558
|
8,207,367
|
-
|
-
|
-
|
|||||||||||||||
|
Compensation Actually Paid to Second PEO
|
-
|
16,199,112
|
1,886,664
|
1,904,420
|
1,775,784
|
|||||||||||||||
|
Average Compensation Actually Paid to
Non-PEO
NEOs |
641,151
|
3,627,261
|
899,231
|
1,158,681
|
960,713
|
|||||||||||||||
|
Net Income (Loss)
|
(307,045
|
)
|
(131,891
|
)
|
(20,145
|
)
|
(23,360
|
)
|
51,918
|
|||||||||||
|
Compensation Actually Paid Versus Adjusted EBITDA ($)
|
||||||||||||||||||||
|
12/31/20
|
12/31/21
|
12/31/22
|
12/31/23
|
12/31/24
|
||||||||||||||||
|
Compensation Actually Paid to First PEO
|
736,558
|
8,207,367
|
-
|
-
|
-
|
|||||||||||||||
|
Compensation Actually Paid to Second PEO
|
-
|
16,199,112
|
1,886,664
|
1,904,420
|
1,775,784
|
|||||||||||||||
|
Average Compensation Actually Paid to
Non-PEO
NEOs |
641,151
|
3,627,261
|
899,231
|
1,158,681
|
960,713
|
|||||||||||||||
|
Adjusted EBITDA
|
100,186
|
125,940
|
206,233
|
248,880
|
347,403
|
|||||||||||||||
|
52
|
2025 Proxy Statement
|
|
Number of Securities
to be Issued Upon
Exercise of
Outstanding Options,
Warrants and Rights
|
Weighted Average
Exercise Price of
Outstanding Options,
Warrants and
Rights(2)
|
Number of Securities
Remaining Available
for Future Issuance
Under Equity
Compensation Plans(3)
|
|||||||||||||
|
Equity compensation plans approved by our shareholders
|
5,798,969
|
(1)
|
$
|
19.47
|
13,757,095
|
||||||||||
|
Equity compensation plans not approved by our shareholders
|
-
|
-
|
-
|
||||||||||||
|
Total
|
5,798,969
|
$
|
19.47
|
13,757,095
|
|||||||||||
|
(1)
|
Represents securities to be issued upon exercise of outstanding RSUs and PRSUs under the LTIP, and outstanding options assumed in the Merger from Legacy Expro. As of December 31, 2024, 2,241,162 shares were subject to outstanding RSUs, 898,410 were subject to outstanding PRSUs and 2,659,396 were subject to outstanding assumed options. The number of shares subject to outstanding PRSUs is based on the target number of shares subject to each award and payments could occur at larger amounts if maximum performance metrics are met. The shares underlying the assumed options are available for issuance under the LTIP and do not reduce the shares available for issuance thereunder, but if such options are forfeited, the underlying shares are not otherwise available for issuance under the LTIP.
|
|
(2)
|
The weighted-average exercise price excludes RSU and PRSU awards that do not have an exercise price. The weighted average grant date fair value of all RSUs is $19.15 and the weighted average grant date fair value of all PRSUs is $27.11, assuming a 100% target performance payout.
|
|
(3)
|
The 13,757,095 shares remaining available for issuance as of December 31, 2024 consist of the following: 4,865,541 shares available under our existing employee stock purchase plan (approximately 82,842 of which are estimated to be issued in the current purchase period) and 8,891,554 shares available under the LTIP, assuming the target number of shares subject to outstanding PRSUs is no longer available for issuance.
|
|
2025 Proxy Statement
|
53
|
AUDIT COMMITTEE REPORT
The information contained in this Audit Committee Report and references in this proxy statement to the independence of the Audit Committee members shall not be deemed to be "soliciting material" or to be "filed" with the
During the last fiscal year, and earlier this year in preparation for the filing with the
| • |
reviewed and discussed the Company's audited consolidated financial statements as of and for the year ended December 31, 2024 with management and with the independent registered public accountants; |
| • |
considered the adequacy of the Company's internal controls and the quality of its financial reporting, and discussed these matters with management and with the independent registered public accountants; |
| • |
reviewed and discussed with the independent registered public accountants (1) their judgments as to the quality of the Company's accounting policies, (2) the written disclosures and letter received from the independent registered public accountants required by Public Company Accounting Oversight Board Independence Rules regarding the independent registered public accountants' communications with the Audit Committee concerning independence, and the independent registered public accountants' independence, and (3) the matters required to be discussed by the applicable requirements of the |
| • |
discussed with management and with the independent registered public accountants the process by which the Company's chief executive officer, chief financial officer and principal accounting officer make the certifications required by the |
| • |
based on the reviews and discussions referred to above, recommended to the Board that the consolidated financial statements referred to above be included in the Company's Annual Report on Form 10-Kfor the year ended December 31, 2024. |
The Audit Committee also met to review and discuss the Company's audited Dutch statutory annual accounts for the financial year 2024 with management and
As recommended by the NYSE's corporate governance rules, the Audit Committee also regularly considers whether, to assure continuing auditor independence, it would be advisable to regularly rotate the audit firm itself.
Notwithstanding the foregoing actions and the responsibilities set forth in the Audit Committee's charter, it is not the duty of the Audit Committee to plan or conduct audits or to determine that the Company's consolidated financial statements are complete and accurate and in accordance with generally accepted accounting principles.
Management is responsible for the Company's financial reporting process, including its system of internal controls, and for the preparation of consolidated financial statements in accordance with accounting principles generally accepted in
The Committee meets regularly with management and the independent registered public accountants, including private discussions periodically with the independent registered public accountants, and receives the communications described above. However, this oversight does not provide us with an independent basis to
|
54 | 2025 Proxy Statement |
AUDIT COMMITTEE REPORT
determine that management has maintained appropriate accounting and financial reporting principles or policies, or appropriate internal controls and procedures designed to assure compliance with accounting standards and applicable laws and regulations. Furthermore, our considerations and discussions with management and the independent registered public accountants do not assure that the Company's consolidated financial statements are presented in accordance with generally accepted accounting principles or that the audit of the Company's consolidated financial statements has been carried out in accordance with generally accepted auditing standards.
Audit Committee of the Board of Directors
Frances M. Vallejo
|
2025 Proxy Statement | 55 |
INFORMATION ABOUT OUR INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM
The following table presents the aggregate fees for services rendered to us by
| 2024 | 2023 | |||||||
|
Audit Fees |
$ |
4,155,403 |
$ |
4,029,232 |
||||
|
Audit-Related Fees |
- |
40,000 |
||||||
|
Tax Fees |
505,115 |
386,765 |
||||||
|
All Other Fees |
82,225 |
45,150 |
||||||
|
Total |
$ |
4,742,743 |
$ |
4,501,147 |
||||
Audit fees consist of the aggregate fees and expenses billed or expected to be billed for professional services rendered by Deloitte and its affiliates for the audit of our consolidated annual financial statements, including the Annual Report on Form 10-Kfor the years ended 2024 and 2023, the review of quarterly financial statements and for services that are normally provided by the independent auditor in connection with statutory and regulatory filings or engagements for those fiscal years, including statutory audits and attest services.
Audit-related fees consist of the aggregate fees billed or expected to be billed for assurance and related services by Deloitte, if applicable, that are reasonably related to the performance of the audit or review of the financial statements and are not reported as audit fees herein. This category includes fees related to services in connection with various registration statement filings, including consents.
Tax fees consist of international tax compliance and corporate tax consulting.
All other fees are the aggregate fees billed for products and services other than "Audit Fees," "Audit-Related Fees" or "Tax Fees", and included services in connection with ESG readiness.
The Audit Committee has adopted procedures for the approval of Deloitte's and
The Audit Committee is updated on the status of the auditor's services and related fees at its regular meetings.
As set forth in the Audit Committee Report on page 54 of this proxy statement, the Audit Committee has considered whether the provision of these non-auditservices is compatible with maintaining auditor independence and has determined that they are.
Policy for Pre-Approvalof Audit and Non-AuditFees
The Audit Committee has an Audit and Non-AuditServices Pre-ApprovalPolicy. The policy requires the Audit Committee to pre-approvethe audit and non-auditservices performed by our independent registered public accounting firm. Under the policy, the Audit Committee establishes the audit, audit-related, tax and all other services that have the approval of the Audit Committee. The term of any such pre-approvalis twelve months from the date of pre-approval,unless the Audit Committee adopts a shorter period and so states. The Audit Committee will periodically review the list of pre-approvedservices and will add to or subtract from the list of pre-approvedservices from time to time. The Audit Committee will also establish annually pre-approvalfee levels or budgeted amounts for all services to be provided by the independent registered public accounting firm. Any proposed services exceeding these levels or amounts will require specific pre-approvalby the Audit Committee. As required under the Audit and Non-AuditServices Pre-ApprovalPolicy, the Audit Committee pre-approvedall services in 2024.
|
56 | 2025 Proxy Statement |
INFORMATION ABOUT OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Audit Committee has delegated to any financial officer of the Company the authority to engage the Company's independent registered public accounting firm in any of the pre-approvedaudit services or audit-related services of the pre-approvalpolicy. The Audit Committee has delegated to the principal accounting officer the authority to engage the Company's independent registered public accounting firm in any of the pre-approvedtax services or permitted non-auditservices for which estimated fees do not exceed cumulatively up to $500,000 annually. In accordance with the Audit and Non-AuditServices Pre-ApprovalPolicy, Deloitte submits the requested services to the Committee Chair for pre-approval.Each request is consistent with the rules of the
|
2025 Proxy Statement | 57 |
TRANSACTIONS WITH RELATED PERSONS
Transactions with Directors, Executive Officers and Affiliates
None.
Registration Rights Agreement
In connection with the Merger, the Company and certain of Legacy Expro shareholders (the "Registration Rights Holders") entered into the Registration Rights Agreement. Pursuant to the Registration Rights Agreement, among other things and subject to certain restrictions, upon request by the Registration Rights Holders, the Company is required to file with the
Amended Registration Rights Agreement
In connection with the Merger, the Company and certain of its shareholders have entered into an Amendment (the "RRA Amendment") to that certain Registration Rights Agreement, dated as of August 14, 2013 (the "Existing Registration Rights Agreement") that became effective on October 1, 2021. The RRA Amendment amended the Existing Registration Rights Agreement in order to facilitate the transactions contemplated by the Registration Rights Agreement described above.
Director Nomination Agreement
As described elsewhere in this proxy statement, in connection with the Merger, the Company and certain shareholders of the Company entered into the Director Nomination Agreement that became effective on October 1, 2021 (the "Closing Date"). The Director Nomination Agreement provides, among other things, that
Procedures for Approval of Related Person Transactions
A "Related Party Transaction" is a transaction, arrangement or relationship in which the Company or any of its subsidiaries was, is or will be a participant, the amount of which involved exceeds $120,000, and in which any related person had, has or will have a direct or indirect material interest. A "Related Person" means:
| • |
any person who is, or at any time during the applicable period was, one of the Company's executive officers or one of its directors; |
| • |
any person who is known by the Company to be the beneficial owner of more than 5% of any class of the Company's voting securities; |
| • |
any immediate family member of any of the foregoing persons, which means any child, stepchild, parent, stepparent, spouse, sibling, mother-in-law,father-in-law,son-in-law,daughter-in-law,brother-in-lawor |
|
58 | 2025 Proxy Statement |
TRANSACTIONS WITH RELATED PERSONS
| sister-in-lawof a director, executive officer or a beneficial owner of more than 5% of any class of the Company's voting securities, and any person (other than a tenant or employee) sharing the household of such director, executive officer or beneficial owner of more than 5% of any class of the Company's common stock; and |
| • |
any firm, corporation or other entity in which any of the foregoing persons is a partner or principal or in a similar position or in which such person has a 10% or greater beneficial ownership interest. |
The Board adopted a written Related Party Transactions Policy and has approved, along with the Audit Committee, the applicable Related Party Transactions at this time. Pursuant to this policy, the Audit Committee will review all material facts of all new Related Party Transactions and either approve or disapprove entry into the Related Party Transaction, subject to certain limited exceptions. In determining whether to approve or disapprove entry into a Related Party Transaction, the Audit Committee expects to take into account, among other factors, the following: (1) whether the Related Party Transaction is on terms no less favorable than terms generally available to an unaffiliated third party under the same or similar circumstances and (2) the extent of the Related Person's interest in the transaction. Further, the policy requires that all Related Party Transactions required to be disclosed in the Company's filings with the
|
2025 Proxy Statement | 59 |
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
OWNERS AND MANAGEMENT
The following table sets forth information with respect to the beneficial ownership of the Company's Common Stock by:
| • |
each person known to the Company to beneficially own more than 5% of the Company's Common Stock; |
| • |
each of the Company's named executive officers; |
| • |
each member of the Board and each director nominee; and |
| • |
all of the Company's directors and executive officers as a group. |
Unless otherwise indicated below, the number of shares of the Company's Common Stock outstanding and the percentage of beneficial ownership is presented as of March 31, 2025.
Beneficial ownership is determined in accordance with the rules of the
Unless otherwise indicated, the address of each person or entity named in the table is 1311 Broadfield Blvd., Suite 400,
|
|
Number of Shares |
% of Shares Beneficially Owned |
||||||||
|
5% shareholders: |
||||||||||
|
Entities affiliated with |
12,133,007 |
|
10.5 |
% |
||||||
|
T. Rowe Price Investment Management, Inc.(2) |
11,705,860 |
10.1 |
% |
|||||||
|
The Vanguard Group, Inc.(3) |
9,975,346 |
8.6 |
% |
|||||||
|
|
8,632,356 |
7.4 |
% |
|||||||
|
|
7,036,231 |
6.1 |
% |
|||||||
|
Directors and Named Executive Officers: |
||||||||||
|
|
61,433 |
* |
% |
|||||||
|
|
1,020,288 |
* |
% |
|||||||
|
|
- |
- |
% |
|||||||
|
|
27,633 |
* |
% |
|||||||
|
|
22,769 |
* |
% |
|||||||
|
|
83,226 |
* |
% |
|||||||
|
|
8,056 |
* |
% |
|||||||
|
|
22,769 |
* |
% |
|||||||
|
|
248,892 |
* |
% |
|||||||
|
|
310,830 |
* |
% |
|||||||
|
|
237,192 |
* |
% |
|||||||
|
|
60,634 |
* |
% |
|||||||
|
All directors and executive officers as a group (12 persons)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17) |
2,103,722 |
1.8 |
% |
|||||||
| * |
Represents less than 1%. |
| (1) |
Represents shares held by client accounts advised and/or managed by |
|
60 | 2025 Proxy Statement |
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
| affiliates are subsidiary businesses of T. Rowe Price Associates, Inc. ("TRP"). In accordance with the Securities and Exchange Commission Release No. 34-39538(the "Release"), TRP's beneficial ownership of securities is disaggregated from that of OHA. |
| (2) |
Based on information included in a Schedule 13G/A filed with the |
| (3) |
Based on information included in a Schedule 13G/A filed with the |
| (4) |
Based on information included in a Schedule 13G/A filed with the |
| (5) |
Based on information included in a Schedule 13G filed with the |
| (6) |
Excludes 7,748 restricted stock units because such award does not begin to vest, and no common stock may be received thereunder, prior to May 30, 2025. |
| (7) |
Excludes 233,052 restricted stock units because such award does not begin to vest, and no common stock may be received thereunder, prior to May 30, 2025. Includes 482,571 time-based vested stock options and 299,532 performance-based vested and exercisable stock options due to the satisfaction of internal rate of retuthresholds. |
| (8) |
|
| (9) |
Excludes 7,748 restricted stock units because such award does not begin to vest, and no common stock may be received thereunder, prior to May 30, 2025. |
| (10) |
Excludes 7,748 restricted stock units because such award does not begin to vest, and no common stock may be received thereunder, prior to May 30, 2025. |
| (11) |
Excludes 7,748 restricted stock units because such award does not begin to vest, and no common stock may be received thereunder, prior to May 30, 2025. Includes 60,415 time-based vested stock options. |
| (12) |
Excludes 7,748 restricted stock units because such award does not begin to vest, and no common stock may be received thereunder, prior to May 30, 2025. |
| (13) |
Excludes 7,748 restricted stock units because such award does not begin to vest, and no common stock may be received thereunder, prior to May 30, 2025. |
| (14) |
Excludes 80,433 restricted stock units because such award does not begin to vest, and no common stock may be received thereunder prior, to May 30, 2025. Includes 120,998 time-based vested stock options and 75,104 performance-based vested and exercisable stock options due to the satisfaction of internal rate of retuthresholds. |
| (15) |
Excludes 72,184 restricted stock units because such award does not begin to vest, and no common stock may be received thereunder, prior to May 30, 2025. Includes 132,706 time-based vested stock options and 82,371 performance-based vested and exercisable stock options due to the satisfaction of internal rate of retuthresholds. |
| (16) |
Excludes 55,536 restricted stock units because such award does not begin to vest, and no common stock may be received thereunder, prior to May 30, 2025. Includes 120,642 time-based vested stock options and 74,883 performance-based vested and exercisable stock options due to the satisfaction of internal rate of retuthresholds. |
| (17) |
Excludes 58,956 restricted stock units because such award does not begin to vest, and no common stock may be received thereunder, prior to May 30, 2025. |
|
2025 Proxy Statement | 61 |
ITEM ONE-ELECTION OF DIRECTORS
The Board has nominated the following individuals for election to the Board, with a term beginning on June 5, 2025 to serve until the Company's 2026 annual meeting of shareholders or until their successors are elected and qualified or upon earlier of death, disability, resignation or removal:
Biographical information for each nominee, as well as for the Company's current executive officers, is contained in "Management-Directors and Executive Officers."
The number of members of the Board will automatically be reduced to seven directors as of the election of directors at the 2025 annual meeting. The Board has no reason to believe that any of its nominees will be unable or unwilling to serve if elected. If a nominee becomes unable or unwilling to accept nomination or election, the number of members of the Board will be reduced for the time being, until a meeting is called to appoint a substitute nominee that the Board recommends.
The affirmative vote of a simple majority of the votes cast at the annual meeting is required to elect each director nominated.
THE BOARD UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS VOTE "FOR" THE ELECTION OF EACH OF THE DIRECTOR NOMINEES.
|
62 | 2025 Proxy Statement |
ITEM TWO-ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION
The Company is asking its shareholders to provide advisory, non-bindingapproval of the compensation paid to its Named Executive Officers, as described in the "Compensation Discussion and Analysis" section of this proxy statement beginning on page 21, and the compensation tables and narrative discussion that follow such section, as required pursuant to Section 14A of the Exchange Act. The Board recognizes that executive compensation is an important matter for the Company's shareholders. This vote is not intended to address any specific item of compensation, but rather the overall compensation of the Named Executive Officers and the philosophy, policies and practices described in this proxy statement.
As described in detail in the CD&A section of this proxy statement, the Company is focused on establishing an executive compensation program that is intended to attract, motivate, and retain key executives and to reward executives for creating and increasing the value of the Company. These objectives are taken into consideration when creating the Company's compensation arrangements, when setting each element of compensation under those programs, and when determining the proper mix of the various compensation elements for each of the Named Executive Officers. The Company periodically reevaluates whether its compensation programs and the levels of pay awarded under each element of compensation achieve these objectives.
As described in the CD&A, the Company believes its compensation program is effective, appropriate and strongly aligned with the long-term interests of its shareholders and that the total compensation package provided to its Named Executive Officers is reasonable and not excessive. As you consider this Item two, the Company urges you to read the CD&A section of this proxy statement for additional details on executive compensation, including information about compensation philosophy and objectives and the past compensation of the Company's Named Executive Officers, and to review the tabular disclosures regarding Named Executive Officer compensation together with the accompanying narrative disclosures in the "Executive Compensation" section of this proxy statement.
As a non-bindingadvisory vote, Item two is not binding on the Board, will not overrule any decisions made by the Board or require the Board to take any specific action. Although the vote is non-binding,the Board and the members thereof responsible for setting executive compensation value the opinions of the shareholders, and will carefully consider the outcome of the vote when making future compensation decisions for the Company's Named Executive Officers. In particular, to the extent there is any significant vote against the Company's Named Executive Officers' compensation as disclosed in this proxy statement, the Company will consider its shareholders' concerns, and the Board will evaluate whether any actions are necessary to address those concerns.
Text of the Resolution to be Adopted
The Company is asking shareholders to vote "FOR" the following resolution:
"RESOLVED, that the compensation paid to the Company's named executive officers, as disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis, compensation tables and narrative discussion is hereby APPROVED."
Vote Required
The affirmative vote of a simple majority of the votes cast is required for approval of Item two. If you own shares through a bank, broker or other holder of record, you must instruct your bank, broker or other holder of record how to vote in order for them to vote your shares so that your vote can be counted on this proposal.
THE BOARD UNANIMOUSLY RECOMMENDS AN ADVISORY VOTE "FOR" THE APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.
|
2025 Proxy Statement | 63 |
ITEM THREE-ADOPTION OF ANNUAL ACCOUNTS FOR 2024
At the annual meeting, you will be asked to confirm and ratify the preparation of the Company's Dutch statutory annual accounts and annual report of the Board in the English language and to adopt the Company's Dutch statutory annual accounts for the year ended December 31, 2024 (the "Annual Accounts"), as required under Dutch law and the Articles.
The Company's Annual Accounts are prepared in accordance with the statutory provisions of Title 9, Book 2 of the Dutch Civil Code and International Financial Reporting Standards ("IFRS") as issued by the
A copy of the Annual Accounts can be accessed through the Company's website, www.expro.com, and may be obtained free of charge by request to the Company's principal executive offices at 1311 Broadfield Blvd., Suite 400,
A representative of
The affirmative vote of a simple majority of the votes cast at the annual meeting is required to adopt the Company's Annual Accounts and to authorize the preparation of the Company's Dutch statutory annual accounts and annual report in the English language.
THE BOARD UNANIMOUSLY RECOMMENDS A VOTE "FOR" THE ADOPTION OF THE COMPANY'S ANNUAL ACCOUNTS AND THE AUTHORIZATION OF THE PREPARATION OF THE COMPANY'S DUTCH STATUTORY ANNUAL ACCOUNTS AND ANNUAL REPORT IN THE ENGLISH LANGUAGE.
|
64 | 2025 Proxy Statement |
ITEM FOUR-DISCHARGE OF MEMBERS OF THE BOARD
Under Dutch law, at the annual meeting shareholders may discharge the members of the Board from liability in respect of the exercise of their duties during the financial year concerned. The discharge is without prejudice to the provisions of the law of
It is proposed that the shareholders resolve to discharge the members of the Board from liability in respect of the exercise of their duties during 2024.
The affirmative vote of a simple majority of the votes cast at the annual meeting is required to approve the discharge from liability of the members of the Board.
THE BOARD UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS VOTE "FOR" THE DISCHARGE OF THE MEMBERS OF THE BOARD FROM LIABILITY FOR 2024.
|
2025 Proxy Statement | 65 |
ITEM FIVE-APPOINTMENT OF AUDITOR FOR DUTCH STATUTORY ANNUAL ACCOUNTS
In accordance with Dutch law and the Company's Articles, the Company shall have its Dutch statutory annual accounts (prepared in accordance with IFRS) audited by a Dutch auditor. The Dutch auditor shall be appointed by the Company's shareholders at the annual meeting. Upon the recommendation of the Audit Committee, the Board proposes to appoint
The affirmative vote of a simple majority of the votes cast at the annual meeting is required to appoint
THE BOARD UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS VOTE "FOR" THE APPOINTMENT OF DELOITTE ACCOUNTANTS B.V. AS OUR AUDITOR WHO WILL AUDIT OUR DUTCH ANNUAL ACCOUNTS FOR THE YEAR ENDING DECEMBER 31, 2025.
|
66 | 2025 Proxy Statement |
ITEM SIX-RATIFICATION OF SELECTION OF INTERNATIONAL INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Audit Committee of the Board has selected
The Board is submitting the selection of
The Audit Committee has the authority and responsibility to retain, evaluate and replace the Company's international independent registered public accounting firm. The shareholders' ratification of the appointment of
THE BOARD UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS VOTE "FOR" THE RATIFICATION OF THE SELECTION OF DELOITTE & TOUCHE LLP AS THE INTERNATIONAL INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE YEAR ENDING DECEMBER 31, 2025.
|
2025 Proxy Statement | 67 |
ITEM SEVEN-AUTHORIZATION OF BOARD TO
REPURCHASE SHARES FOR ANY LEGAL PURPOSE
In accordance with Dutch law and the Company's Articles, the Company may only acquire its own fully paid-upshares with consideration if and insofar the general meeting has authorized the Board in that respect. Such authorization shall be valid for a period of no longer than 18 months. In the authorization, the general meeting shall state the number of shares that may be acquired (i.e., the total number of shares that may be held as treasury shares, including treasury shares already held pursuant to prior repurchases), how the shares may be acquired and the limits within which the price of the shares must be set. No authorization is required when the Company acquires shares in its capital for the purpose of transferring those shares to employees of the Company or of a group company, under a plan applicable to such employees.
At the annual general meeting in 2024, the Board was granted the authorization to repurchase shares in such way that a maximum of 10% of the issued capital may be repurchased and at a price between $0.01 and 105% of the market price on the NYSE. The authorization was granted for a period of 18 months starting from the date of the 2024 annual meeting.
Therefore, for the annual meeting, the Board proposes to authorize the repurchase of shares for any legal purpose under the following same conditions:
| (i) |
the shares may be repurchased up to a total of 10% of the issued share capital (currently consisting of 122,121,171 shares); |
| (ii) |
the shares may only be repurchased at an open market purchase or in a private purchase transaction; |
| (iii) |
the shares may only be repurchased at a price between $0.01 and 105% of the market price on the NYSE; and |
| (iv) |
the authorization of the Board is valid for a period of 18 months starting from the date of the annual meeting. |
The affirmative vote of a simple majority of the votes cast at the annual meeting is required to authorize the Board to repurchase shares for any legal purpose under the relevant conditions.
THE BOARD UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS VOTE "FOR" THE AUTHORIZATION OF THE BOARD TO REPURCHASE SHARES FOR ANY LEGAL PURPOSE.
|
68 | 2025 Proxy Statement |
ITEM EIGHT-AUTHORIZATION OF BOARD TO
ISSUE SHARES FOR ANY LEGAL PURPOSE
At the annual general meeting in 2024, the Board proposed to authorize the Board to issue shares up to 20% of the issued share capital, for any legal purpose, at the stock exchange or in a private purchase transaction, and during a period of 18 months. The authorization also included the authority to restrict or exclude preemptive rights upon an issue of shares. At the 2024 annual general meeting, the shareholders approved such proposal.
Therefore, for the annual meeting, in accordance with customary practice in
| (i) |
the shares may be issued up to a total of 20% of the issued share capital as of the date of the annual meeting; and |
| (ii) |
the authorization of the Board is valid for a period of 18 months starting from the date of the annual meeting. |
Notwithstanding the foregoing, we expect to propose renewal of this authorization annually at the annual general meetings in subsequent years. Please be informed that although the previous authorization has been included in the Articles, no amendment to the Articles is necessary to validly authorize the Board to issue shares, as the authorization granted in the annual meeting will replace the one included in the Articles.
In addition, we note that, because we are a NYSE-listed company, our shareholders continue to benefit from the protections afforded to them under the rules and regulations of the NYSE and
The affirmative vote of a simple majority of the votes cast at the annual meeting is required to authorize the Board to issue shares for any legal purpose under the relevant conditions.
THE BOARD UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS VOTE "FOR" THE AUTHORIZATION OF THE BOARD TO ISSUE SHARES FOR ANY LEGAL PURPOSE.
|
2025 Proxy Statement | 69 |
SHAREHOLDER PROPOSALS
Pursuant to the Company's Articles, general meetings will be held in
The agenda for the 2026 annual meeting is expected to include, in addition to other matters, any matter the consideration of which has been requested by one or more shareholders, representing alone or jointly with others at least such percentage of the issued capital stock as determined by our Articles and Dutch law, which is currently set at three percent. Shareholders who desire to submit a proposal for action, including a proposal to appoint a director, at the 2026 annual meeting other than pursuant to Rule 14a-8of the Exchange Act must comply with Article 30 of the Company's Articles. The request to consider such matter must be received by us no later than on the 60th day prior to the day of the 2026 annual meeting accompanied by a statement containing the reasons for the request. We currently expect our 2026 annual meeting to be held on or about June 4, 2026, with mailing to commence on or about April 10, 2026. Requests received later than the 60th day prior to the day of the meeting (anticipated to be Sunday, April 5, 2026), will be considered untimely. In addition, the deadline for providing notice to the Company under Rule 14a-19,the
Any proposals sought for inclusion in the proxy statement for the 2026 annual meeting must comply with Rule 14a-8under the Exchange Act and be submitted by December 12, 2025.
In order for any matters to be included in the Company's proxy statement or presented at the 2025 annual meeting, the qualified shareholder(s) must submit the matter to the Company's Secretary at 1311 Broadfield Blvd., Suite 400,
|
70 | 2025 Proxy Statement |
HOUSEHOLDING MATTERS
Shareholders who share a single address will receive only one proxy statement or Notice at that address unless the Company has received instructions to the contrary from any shareholder at that address. This practice, known as "householding," is designed to reduce the Company's printing and postage costs. However, if a shareholder residing at such an address wishes to receive a separate copy of these materials or of future materials (as applicable), he or she may contact the Company's Corporate Secretary at (713) 463-9776,or write to
WHERE YOU CAN FIND MORE INFORMATION
The Company files annual, quarterly and current reports and other information with the
|
2025 Proxy Statement | 71 |
SCAN TO VIEW MATERIALS & VOTE EXPRO GROUP HOLDINGS N.V. VOTE BY INTERNET-www.proxyvote.com or scan the QR Barcode above (INCORPORATED IN
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice and Proxy Statement and 2024 Annual Report are available at www.proxydocs.com/xpro V64832-P29403-P29404
Attachments
Disclaimer


Proxy Statement (Form DEF 14A)
Proxy Statement (Form DEF 14A)
Advisor News
- How much could failure to fund Social Security cost average Americans?
- How can more Americans achieve financial independence?
- Savers vs. spenders: How money management attitudes impact financial confidence
- Demonstrating the value of life insurance to Gen Z
- Poor money habits are a dealbreaker in a new relationship
More Advisor NewsAnnuity News
- Canvas steps into the direct-to-consumer market that has yet to take off
- The next growth phase in life/annuities depends on modernization
- CA judge certifies class action in teachers’ lawsuit over in-plan annuity fees
- Globe Life Inc. (NYSE: GL) Records 52-Week High Thursday Morning
- AM Best Managing Director Joins ‘Target Topics’ Podcast to Discuss State of Delegated Underwriting Authority Enterprises Market
More Annuity NewsHealth/Employee Benefits News
- Gov. Stitt names OHCA interim director
- Iowa health insurers propose premium increases for ACA customers
- Atrium pushes back after State Health Plan leaves healthcare network out of Tier 1
- BUILDING A COMPETITIVE BENEFITS PACKAGE IN 7 EASY WAYS
- People with this Medicare plan could soon go out-of-network at UHealth hospitals
More Health/Employee Benefits NewsLife Insurance News
- USAA introduces Secure Start whole life program for children
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on South Korea’s Non-Life Insurance Market
- Horace Mann Strengthens Customer Relationships and Accelerates Long-Term Growth Through Transactions with Medical Mutual of Ohio
- Regulators: ‘No firm conclusions’ from first offshore reinsurance filings
- Allianz Life Study Finds Americans Struggle to Shift From Retirement Saving to Spending
More Life Insurance News